prefeasibility report: qppl/2018/01environmentclearance.nic.in/writereaddata/online/...the indian...
TRANSCRIPT
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 1
PRE-FEASIBILITY REPORT
For Proposed
Active Pharmaceutical Ingredients (APIs) and
API Intermediates Manufacturing Unit
At,
A-106/1, MIDC Paithan Industrial Area, Village: Mudhalwadi, Taluka: Paithan,
Aurangabad, Maharashtra. Pin Code: 431148
For
M/s. Quantinental Pharmachem Private
Limited
Recognized
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 2
INDEX Chapter No. Contents Page No.
1. Executive Summary 4-6
2. Introduction of the Project/ Background Information 7-9
2.1 Identification of the Project and Project Proponent 7
2.2 Nature of the Project 7
2.3 Need of project with description for region and country 8
2.4 Demand and Supply Gap 8
2.5 Employment generation due to project 9
3. Project Description 10-29
3.1 Type of Project 10-11
3.2 Location of Project 12-14
3.3 Products & Raw Material. 15
3.4 Manufacturing Process 15-26
3.5 Plant Machinery and Equipment’s 26
3.6 Technology Selection 26
3.7 Raw Material for finished Product 27
3.8 Availability of Resources 27-28
3.9 Quantity of waste to be generated 28-29
3.10 Reuse/ Recycle/ Recovery Systems proposed along with
Details
29
4. Site Analysis 30-32
4.1 Connectivity 30
4.2 Land form, Land use, Land ownership 30
4.3 Topography 31
4.4 Soil classification 31
4.5 Climate data for secondary sources 31
4.6 Social infrastructure Demand 31
5. Planning Brief 32
5.1 Planning Concept 32
5.2 Facilities 32
5.3 Land Use Planning 32
5.4 Population Projection 32
6. Proposed Infrastructure 33-36
6.1 Industrial area 33
6.2 Residential area 33
6.3 Green belt 33
6.4 Connectivity 33
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 3
6.5 Water management 33
6.66 Sewerage system/ETP 33-34
6.7 Air Pollution 34-35
6.8 Solid waste management 35-36
6.9 Power requirement & supply /source 36
7. Rehabilitation and Resettlement 37
7.1 Policy to be adopted 37
8. Project Schedule & Cost Estimate 38
8.1 Time schedule for the project 38
8.2 Estimated Project cost 38
9. Analysis of Proposal 39
9.1 Financial and Social Benefit 39
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 4
Chapter 01
Executive Summary
The project is being promoted by M/s Quantinental Pharmachem Pvt. Ltd. (QPPL).The proposed
plant is located at A-106/1, MIDC Paithan Industrial Area, Pin Code: 431148, Village: Mudhalwadi,
Taluka: Paithan, Aurangabad, Maharashtra.
QPPL is “Start-Up India” recognized as a startup by the Department of Industrial Policy and
Promotion with Certificate No.: DIPP19012. QPPL is also having 50% shareholding of Women
entrepreneurs and both Directors as women for Women empowerment.
The aim of the Quantinental Pharmachem Pvt. Ltd is to set up the API and its intermediate
manufacturing facility. QPPL is planning to start R&D and subsequent commercialization of
innovative and patented chemicals which can prevent further import from other countries. The
company is in the process of setting up State of art manufacturing unit and manufacture any
product based on market and according to the changing marketing environment. The project is
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 5
being promoted to cater domestic market, Export & Govt. supply as per the requirements of the
prospective customers.
The proposed products shall fall under category of Synthetic Organic Chemicals. As per the
EIA Notification 2006 & amendments thereof, for manufacturing of Bulk drug & intermediate
chemicals require environmental clearance from MoEF&CC under the 5 (f) category A.
The list of proposed products is as per Table No. 1.1;
Table No. 1.1
Sr.no Name of the Product Pharmaceutical Activity
Qty MT per Month
1. m- Bromoanisole Phase-transfer catalyst 0.800
2. Etorocoxib Non-steroidal anti-inflammatory
0.200
3. Ethyl Triphenylphosphonium Bromide Phase-transfer catalyst 10.0
4. Fluconazole Anti-fungals 0.475
5. Linezolid Anti-biotic 0.094 6. Telmisartan Anti-hypertensive 0.400 7. Tetrabutyl Ammonium Bromide Phase-transfer catalyst 0.130 8. Glimepiride Anti-diabetic 0.150 9. Tri-Ortho Phenyl Phosphine Phase-transfer catalyst 02.00 10. Cilnidipine Anti-hypertensive 0.150
11. Triclabendazole Anti-helmintic 0.082 12. Voglibose Anti-diabetic 0.005 13. Darunavir Anti-HIV 0.100 14. Montelucast Sodium Anti-allergic 0.750 15. Losartan Anti-hypertensive 0.975
16. Sparfloxacin Anti-bacterial 0.05 17. Salbutamol Sulphate Bronchodilators 02.00 18. Pantoprazole Sodium Proton Pump Inhibitor 0.450 19. Fenofibrate Anti-hyperlipidemic 0.500 20. Clopidogrel Hydrogen Sulphate Anti-platelet 0.175 21. Rosuvastatin Calcium Anti-hyperlipidemic 0.500 22. Domeperidone Anti-emetic 0.100 23. Nebivolol Hydrochloride Anti-hypertensive 0.360 24. R&D Products 3 no. 0.100
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 6
Area Requirement- The total plot area in possession is 2499 Sq.mt.
Water Requirement: The total water requirement will be 42 CMD and shall be supplied by [MIDC]
Maharashtra Industrial Development Corporation, Paithan.
Power Requirement: The total power requirement will be 150 KVA. The source of electricity
supply is Maharashtra State Electricity Distribution Company Limited (MSEDCL).
Man Power: The total manpower requirement will be 10 nos. of skilled and unskilled Category.
Project Cost: The total cost of the project will be around Rs. 404.96 Lakhs. Cost for Environment
Management Plan is Capital Cost 94.5 Lakhs/annum and Recurring Cost: Rs. 7.17 Lakhs/annum.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 7
Chapter 02
Introduction of the Project/Background Information
2.1 Identification of the Project and Project Proponent-
The project is being promoted by M/s Quantinental Pharmachem Pvt. Ltd. (QPPL). QPPL
is“Start-Up India” recognized as a startup by the Department of Industrial Policy and Promotion
with Certificate No.: DIPP19012. QPPL is also having 50% shareholding of Women entrepreneurs
and two Directors as women for Women empowerment. Mrs. Varsha A Padalkar and Mrs.
Manisha M Thube and Mr. Mahesh Thube are the Directors of the Company.
The aim of the Quantinental Pharmachem Pvt. Ltd is to set up the API and its intermediate
manufacturing facility. The directors of M/s Quantinental Pharmachem Pvt. Ltd. intend to
extrapolate business by way of Manufacturing, Exporting & selling of all kinds of API and
intermediates and chemicals as Raw materials.
For this project the proponent is having the land in MIDC at plot no. A-106/1, Paithan, Taluka-
Paithan, District-Aurangabad. As per the present pollution control norms, the project is having Zero
Liquid Discharge.
This Pre-Feasibility Report is prepared for forming a framework for EIA study, Scoping and
finalizing the Terms of Reference. M/s Quantinental Pharmachem Pvt. Ltd. (QPPL) has retained
the services to the M/s. Green Circle Consultants (India) Pvt. Ltd., Vadodara, Gujarat as EIA
Consultant for this project. M/s Green Circle Consultants (India) Pvt. Ltd. is provisional
accredited EIA Consultant with the National Accreditation Board for Education and Training
(NABET), an organization working under the Quality Council of India (QCI), a mandatory
requirement for working as on projects requiring EC.
2.2 Nature & Magnitude of project
The proposed products are Active Pharmaceutical Ingredient’s (API) and API intermediates of
Pharma products. The project falls within 5.0 km of notified eco-sensitive area (as per Gazette
Notification No. S.O. 2202E) hence it falls under Category A, section 5(f) of EIA notification
September 2006 and its Amendment.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 8
2.3 Need of project and its importance to the country and region
The project is being promoted by M/s. Quantinental Pharmachem Pvt. Ltd. (QPPL), with a view
to tap tremendous scope of the pharmaceutical industry supported by the following facts. The
drugs and pharmaceutical industry have shown significant growth and improvement in
profitability. This growth rather is more significant as it has been achieved despite frequent
changes made in the drug policy and has been achieved as an outcome of some dynamic strategies
adapted by the industry. The pharmaceutical industry is considered lifeline industry as it is directly
concerned with the health of the people.
The company is in the process of setting up State of art manufacturing unit and manufacture any
product based on market and according to the changing marketing environment. The project is
being promoted to cater domestic market, Export & Govt. supply as per the requirements of the
prospective customers.
The unit will use good faith efforts to employ local people from the nearby villages depending upon
the availability of skilled & un-skilled manpower surrounding the project site. In operation phase,
the proposed project would require significant workforce of nontechnical and technical grade.
2.4 Demand supply gap and market scenario
Natural Product and broadly Chemical Industry is one of the oldest industries in India, which
contributes significantly towards industrial and economic growth of the nation. It is highly scientific
type of industry and provides valuable raw material/chemicals for various types of industries such
as Food, Feed, Pharma, Nutraceutical and Personal Care etc., are required in almost all walks of life.
The Indian Chemical Industry forms the backbone of the industrial and agricultural development of
India and provides building blocks for downstream industries.
The Indian pharmaceutical industry has registered phenomenal growth since independence from
an annual turnover of 10 million; the industry is expected to achieve a turnover of Rs. 20,000 Cr by
2020. India today enjoys the recognition and respect as one of the leading producers of quality
pharmaceuticals products and formulations in the world. In the present scenario every drug
industry has to operate under strict norms of cGMP governed by Drugs & Cosmetics Act. 1940 in
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 9
order to maintain quality at par with the global requirement. Hence immense potential in exports is
another opportunity for this industry.
2.5 Employment Generation
The Project creates direct & indirect employment opportunities to people living in the surrounding
region. The Management of the Company has always preferred to engage (employment) local
people from the nearby villages depending upon skilled & unskilled man-power available and train
them in the required field. Total direct employment is around 10 people initially. After that as when
required it will be upgraded.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 10
Chapter 03
Project Description
3.1 Type of project
Quantinental Pharmachem Pvt. Ltd is to set up the API and it’s intermediate manufacturing
facility. QPPL is planning to start R&D and subsequent commercialization of innovative and
patented chemicals which can prevent further import from other countries.
The details of project are given in the Table 3.1.
Table 3.1 Project Details
# particulars Details A. Nature & Size of
the Project List of the products is mentioned in Table no.1
B. Category of the Project
As per EIA Notification dated 14th Sep., 2006 as amended from time to time; the project falls in Category ‘A’, Project or Activity -5(f).
C. Location Details Village Mudhalwadi Tehsil Paithan District Aurangabad State Maharashtra Latitude 19031’ 56.2” N Longitude 75023’ 02.2” E Mean sea level 470 m
D. Area Details Total Project Area and Green belt development area
Total area required:- 2499 Sq.Mt Built up area for Factory shed:- 243.04 Sq.Mt Built up area for storage:- 236.04 Sq.Mt Built up area for office:- 13.36 Sq.Mt Open Space for utility:- 65.73 Sq.Mt` Other:- Open Land 1940.83 Sq.Mt
E. Environmental Setting Details (with approximate aerial distance & direction from plant site) 1. Nearest Village Mudhalwadi approx. -0.75 Km 2. Nearest town and
City Paithan–6 Km
3.
Nearest National Highway / State Highway
Aurangabad – Paithan Road
4. Nearest Railway station
Aurangabad Railway Station - 37.06 Km
5. Nearest Airport Aurangabad Airport –36.70 Km 6. National Parks,
Wildlife Sanctuaries, Biosphere Reserves, Tiger/
Jayakwadi Bird Sanctuary reserved for the migratory birds, is 1.8km towards South-West Direction [As per Gazette Notification S.O. 2202 (E) amended Dated 12th July 2017]
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 11
Elephant Reserves, Wildlife Corridors etc. within 10 km radius
7. Reserved Forests (RF)/Protected Forests (PF)
No
8. Water Body (within 10 km radius)
Jayakwadi Dam- 1.8 Km. Google image is attached as Annexure.
9. Seismic Zone Seismic Zone - II as per IS: 1893 (Part-I): 2002 F Cost Details
Total Cost of the Project
Rs. 404.96 Lakhs
Cost for Environment Management Plan
Capital Cost: Rs. 94.5 Lakhs Recurring Cost: Rs. 7.17 Lakhs/annum
No. Description Capital Cost (Rs. in Lakhs)
Recurring Cost per annum (Rs. in Lakhs)
1. Air Pollution Control system 21.00 1.05 2. Water Pollution Control 65.0 4.0 3. Environment monitoring and
Management 1.5 0.40
4. Rain water Harvesting 1.00 0.10 5. Occupational Health 1.00 0.20 6. Green Belt 1.00 0.82 7. Solid waste management 3.00 0.50 8. Energy Saving Devices and
Solar Heating System 1.00 0.10
Total 94.5 7.17
G Basic Requirements for the project Water Requirement
Total water consumption: 42.0 CMD (Source: - MIDC, Paithan)
Loss due to consumption and evaporation: 21.7 CMD
Total effluent generation & used for plantation: 9.8 CMD Effluent Treatment System (capacity)
Zero Liquid Discharge plant proposed
Power Requirement/ Boiler details
150 KVA (Source: - MSEDCL) Boiler details 600 kg/hr; Fuel – Bricks. DG Set 80KVA
ManPower Requirement
10 nos. (Source: - Unskilled / Semi-Skilled - Local Area; Skilled- Local & Outside)
H Working Days 300 days/annum
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 12
3.2 Location of Project
The proposed production shall be at A-106/1, MIDC Paithan Industrial Area, Village: Mudhalwadi,
Taluka: Paithan, Aurangabad, Maharashtra. Pin Code: 431148. The Geographical location of this
industry is 19031’ 56.2” N Latitude and 75023’ 02.2” E Longitude with an elevation 470 m. of above
mean sea level. This candidate site is in premises of MIDC Industrial Area which is meant for
various types of industries. Government has provided all infrastructure like electrical power,
continues water supply with purification from water, the internal road network, external approach
road. Annexure I shows the distance of Jayakwadi Dam to project site.
Fig. No. 3.1 Google Image
19031’ 56.2” N Latitude 75023’ 02.2” E Longitude
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 13
Figure 3.2: Location map of the Project
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 14
Figure 3.3: Master Layout
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 15
3.3 Details of Alternate Site
No alternate site was examined as already existing infrastructure is present.
The Industrial area of Paithan provides all necessary facilities viz. link roads, sewerage, sanitary
facilities, modern state of the art communication systems, banking and commercial facilities for
development of industrial units. The industrial township is well connected with the adjacent states
and other part of India through a network of roads, which facilitates travelling as well as
transportation of goods both inwards and outwards. This further facilitates the marketing of
products anywhere in the country. There is a regular flow of workers from nearby as well as far off
Aurangabad city. Power connection required for the units are easily available especially in
Industrial towns promoted by the state government.
There is no sensitive establishment in the vicinity such as health resort, hospital, archaeological
monuments, sanctuaries, etc.
3.4 Products and Raw Materials-
Sr.no Name of the Product Pharmaceutical Activity
Qty MT per Month
1. m- Bromoanisole Phase-transfer catalyst 0.800
2. Etorocoxib Non-steroidal anti-inflammatory
0.200
3. Ethyl Triphenylphosphonium Bromide Phase-transfer catalyst 10.0
4. Fluconazole Anti-fungals 0.475
5. Linezolid Anti-biotic 0.094 6. Telmisartan Anti-hypertensive 0.400 7. Tetrabutyl Ammonium Bromide Phase-transfer catalyst 0.130 8. Glimepiride Anti-diabetic 0.150 9. Tri-Ortho Phenyl Phosphine Phase-transfer catalyst 02.00 10. Cilnidipine Anti-hypertensive 0.150
11. Triclabendazole Anti-helmintic 0.082 12. Voglibose Anti-diabetic 0.005 13. Darunavir Anti-HIV 0.100 14. Montelucast Sodium Anti-allergic 0.750 15. Losartan Anti-hypertensive 0.975
16. Sparfloxacin Anti-bacterial 0.05 17. Salbutamol Sulphate Bronchodilators 02.00 18. Pantoprazole Sodium Proton Pump Inhibitor 0.450 19. Fenofibrate Anti-hyperlipidemic 0.500 20. Clopidogrel Hydrogen Sulphate Anti-platelet 0.175 21. Rosuvastatin Calcium Anti-hyperlipidemic 0.500 22. Domeperidone Anti-emetic 0.100 23. Nebivolol Hydrochloride Anti-hypertensive 0.360 24. R&D Products 3 no. 0.100
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 16
There are total 24 numbers of products. The detailed manufacturing processes of the product are
mentioned below;
1. Name of the Product –m- Bromo Anisole
Quantity per Month -800.00 Kg
Batch Output- 400 Kg
Number of batches per Month - 2
Number of working days- 25
Detailed Manufacturing Process-
3- Bromo Nitro Benzene is Charged in toluene, in a Glass lined Reactor at ambient temperature. To
the reaction mass at ambient is charged catalyst and potassium hydroxide. The temperature of the
reaction mass is maintained below 55 0C and controlled with cooling water circulation in the jacket
of the Reactor. Reaction completion is confirmed by analyzing sample on GC, If the result is within
acceptable range, to the resulting slurry, Methanol is added slowly. The reaction mass is then
washed with water to remove water soluble salts. The organic layer is again washed dilute
sulphuric acid and then with water. The organic mass is subjected to distillation and toluene is
recovered initially, and then pure MBA is distilled, stored and packed. Recovered Toluene is
recycled for the successive batches.
Table no 1: Input and output and mass Balance of m- Bromo Anisole
Input UOM Qty Output Qty Remark
MNBB kg 500 Product MBA 400 Final Product
Toluene kg 731 Toluene 584.8 Recovered and recycled
Methanol kg 200 Aqueous Effluent HCOD
1191.2 To ETP for treatment
KOH kg 283 Distillation residue
100 For CHWTSDF
NaOH kg 157 Toluene 10 Distillation loss
TBAB kg 95 Toluene 10 In aq.Effluent
Sulphuric acid kg 30 ----------------- ---------- -----------------------
Water kg 300 -------------- ----------- -----------------------
Total 2296 Total 2296 ----------------
Route of Synthesis for m-Bromo Anisole: -
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 17
N+
O O-
m-Nitro Bromo benzene(M.W. 202)
Br
+ KOH + CH3OH
O
Br
m Bromo Anisole(M.W. 187)
+ KNO2+ H20
Process Flow Diagram for m-Bromo Anisole.
1. Toluene 731 kg 2. MNBB 500 kg 3. Methanol 200 kg 4. KOH 283 kg 5. TBAB 95 kg 6. NaoH 157 kg 7. Sulphuric acid 30 kg 8. Water 300 kg
Reactor Aq.Effluent to ETP 1191.20kg
kg
Vacuum
Distillation Reactor
Recovered Toluene: - 584 kg
Organic Residue for II nd Recovery 100 kg
MBA Product: - 400 kg Total: - 1896 kg Total: - 2296
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 18
Table no. 2:-Pollution load of m- Bromo Anisole. Effluent in m3, rest all figures are in kg
Stage Effluent in lit
Solvent Residue
Carbon Hyflow Spent Solvent
Gas Generated
Inorganic Salt
Organic Residue LCOD HCOD Name Qty
I ------ 1191.20 ----- ------ ------- ----- ------ ----- ------- 100
M ------- 2382.40 ----- ----- ----- ---- ----- ---- ---- 200
D -------- 95.296 ------- ----- ---- ----- ----- ---- ----- 08.00 M- Pollution load per month
D- Pollution load per day
1. No gas is produced or generated during the reaction processing.
2. The reaction is not exothermic or run away or pressure.
3. Toxic and hazardous raw material used 1. Toluene 2. Sulphuric acid.
Table no. 3:- Solvent Balance of m- Bromo Anisole.
Sr.No
/ Stage
Qty in Kg/Day Name of
the solvent
Qty Used
Recovered [Distilled]
Fugitive loss
Distillation
Process loss
To wast
e Wate
r
Distillation
Residue
Product
drying loss
Spent
Solvent
Fresh Make Up
I Methanol 16 Nil Nil Nil 16 Nil Nil Nil 16
I Toluene 58.48 46.72 ------- 0.8 0.8 8 ----- ------ 1.12
I Water 24 --------- 0.16 ------ 23.84 ---- --- ---- 24
Table no. 4:- Matrix showing Molecular weight, Moles, molar ratio andconsumption
Name of Key RM
Details Mol.Wt Qty kg
Moles Molar Ratio
Existing Consumption
Proposed Consumptio
n
Net Consumpt
ion
Toluene Solvent ---- 731 ---- ---- ----- 147 147 MNBB Raw
Material 202 500 2.475 1 ------ 500 500
NaoH Reagent 40 157 3.925 1.58 ---- 157 157 KOH Regent 56 283 5.05 2.041 ------- 283 283
TBAB Catalyst 322.37 95 0.295 0.11 ------- 95 95 Water Solvent ------- 300 ------ ----- ----- ----- -----
Note: - Solvents is in terms of volume and not based on mole ratio.
Key Raw materials are considered as they are involved to build the desired molecule.
The above figures of the respective raw material are representative of a batch.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 19
2. Name of the Product—Etoricoxib
Qty/Month 200.00kg. Batch Output 100 kg No of Batches/ Month 2 No of working days 25
Detailed Manufacturing process of Etoricoxib -
In a clean and dry Reactor is charged a mixture of KetoSulphone and 3-chloro dimethyl
aminehexafluro phosphate at ambient. To the reaction mass is added slowly potassium
tertairybutoxide in 2-3 hrs at ambient. The reaction mass is stirred for 2 hrs and the temperature of
the reaction mass is raised to reflux. Reaction completion is ensured on TLC, if the result complies,
the reaction mass is cooled to ambient and then quenched in acid water mixture. After completion
of quenching operation toluene is added and stirred for 20-30 minutes stalked for 30-40 minutes.
The layer is separated and distilled for recovery.
The recovered Toluene is recycled. To the aq layer, ammonia is added at ambient to adjust pH of the
reaction mass to 7-7.5.The product as base is extracted in Toluene. The toluene layer is separated
and aq layer is let to ETP for treatment. To the toluene layer p-Nitro Toluene Sulphonic acid added
and the reactions mass is stirred for 2030 minutes.The product as salt is centrifuged and spin dried.
The salt of Etoricoxib base is basified with ammonia solution and filtered to get Crude Etoricoxib
,Aq.Layer is send to ETP for treatment. The crude Etoricoxib is purified in Isopropyl acetate. The
pure Etoricoxib is centrifuged to get pure Etoricoxib, which is dried in tray dryer. The mother liquor
is distilled and recycled.
Table No. 1:- Input and output and mass Balance of Etoricoxib
Input UOM Qty Output Qty Remark
KetoSulphone kg 100 Etoricoxib 100 Final Product
KOBt kg 40 Toluene 2660 Recovered and recycled
Intermediate I kg 115 Toluene 10.7 Distillation loss
Tetrahydrofuran kg 250 Aq.Effluent HCOD 1293 To ETP for Treatment
p-NTSA kg 100 Tetra Hydrofuran 225 Recovered and recycled
Acetic acid kg 150 Tetra Hydro Furan 20 Evaporation loss
Toluene kg 2800 Carbon 7 CHWTSDF
Activated Carbon kg 7 Hyflow 7 CHWTSDF
Hyflow kg 7 Isopropyl acetate 230 Recovered and recycled
Aq.Ammonia kg 370 Isopropyl acetate 05 Distillation loss
Isopropyl acetate kg 250 Solvent Distillation Residue
26.3 Send to CHWTSDF
Water kg 400 Product Drying loss 05 Evaporation loss during drying of product-
Total kg 4589 Total 4589 -----------------
KOBt—Potassium Tertiary Butoxide Intermediate I- 2-Chloro-1,3bis[dimethylamino ] trimethyl hexa fluoro phosphate P-NTSA-p-Nitro Toluene Sulphonic acid.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 20
N
O
SH
O
O
KetosulphoneMol.Wt 289.35
Route of Synthessi for ETORICOXIB
+ N
Cl
NPF6 + OK
Chloro Compound
Mol.Wt306.62
SO3H
Tertiary Butoxide
Mol.Wt 112.21
PTSA
Mol.Wt 172.50
THF, Acetic acid, Ammoina.Tolueen
NO
SH
O
O
SO3H
PTSA Salt of EtoricoxibMol.Wt 531.04
+
OH
Mol.Wt 74.12
KPF6 + NH3+
CH3CH2OH
Ammoina, Water,Toluene
Isopropyl acetate, Carbon,Hyflow
N
NO
SH
O
O
N
Cl
Cl
ETORICOXIBMOL.WT 358.84
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 21
Process flow Diagram-
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 22
Table No.2:-Pollution load of Etoricoxib. Effluent in m3, Rest all figs in kg.
Stage Effluent in M3
Solvent Residue
Carbon Hyflow Spent Solvent
Gas Generated
Inorganic Salt
Organic Residue
LCOD HCOD Name Qty
I ------ 1.293 26.3 7 7 ----- ------ ----- ---- -----
M ------- 2.586 52.60 14 14 ------ ------ ------ ----- ---- D -------- 0.103 2.104 0.56 0.56 ------ ----- ----- ---- -----
M- Pollution load per month, D- Pollution load per day.
No gas is produced or generated during the reaction processing. The reaction is not exothermic or run away or pressure. Toxic and hazardous raw material used - 1. Toluene 2. Sulphuric acid.
Table No.3:- Solvent Balance of Etoricoxib.
Sr.No/ Stage
Qty in Kg/Day Name of
the solvent
Qty Used
Recovered [Distilled]
Fugitive loss
Distillation Process
loss
To waste Water
Distillation Residue
Product drying
loss
Spent Solvent
Fresh Make
Up
I Toluene 2800 2660 ----- 25 10 ---- ---- 140
I Tetra
Hydrofuran 250 225 ----- 20 5 ---- ---- --- 25
I Isopropyl
acetate 250 230 230 05 --- 16.30 --- --- 20
I Water 400 ----- ------ -------- 400 ---- --- --- 400
Table No. 4: - Matrix showing Molecular weight, Moles, molar ratio & consumption
The below figures of the respective raw material are representative of a batch.
Name of Key RM
Details Mol.Wt Qty kg
Moles Molar Ratio
Existing Consumption
Proposed Consumption
Net Consumption
KOBT Reagent 112.3 40 0.356 --- --- --- --- KetoSulphone Raw
material 289.35 100 0.345 --- --- --- ---
Chloro compound
Raw material
306.62 115 0.375 --- --- --- ---
PTSA Reagent 172.30 100 0.580 --- --- --- --- Acetic acid Reagent 60 150 2.5 7.20 ---------- 150 150
THF Solvent ---- 230 ----- ----- ------------- 25 25 Toluene Solvent ---- 2800 ------ ------ ---------- 140 140
IPAC Solvent ---- 250 ------ ----- ---------- 25 25 Water Solvent --- 400 ------ ----- ----------- 400 400
Aq.Ammonia Reagent --- 370 ---- --- -------- 370 370
Note: - Solvents is in terms of volume and not based on mole ratio.
Key Raw materials are considered as they are involved building the desired molecule.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 23
3. Name of the Product: Ethyl Triphenyl phosphonium Bromide
Qty/Month 10.00 MT.
Batch Output 135 kg
No of Batches/ Month 74
No of working days 25
Detailed Manufacturing Process-
Toluene is charged in a SS Reactor at ambient temperature. Triphenyl phosphine is charged
under stirring at ambient temperature. The reaction mass is heated to 40-50 °C and slowly ethyl
bromide is added in 4-5 hrs. After complete addition of ethyl bromide the reaction mass is stirred
for 12 hrs at 40-45°C. The temperature of the reaction mass is raised to 80°C and maintained for 20
hrs. The reaction mass is cooled to 20 °C and stirred for 3 hrs. The reaction mass is centrifuged and
washed with toluene, spin-dried and unloaded and dried at 50 °C to get dry Ethyl Triphenyl
phosphonium bromide.
Table No. 1:- Input ,Output and mass Balance.
Sr.No Input UOM Batch Qty
Output Qty Remark
1 Triphenyl Phosphine
kg 100 ETPPBr 135 Final Product
2
Toluene kg 150 Toluene 125.20 Recovered and used 3 Ethyl Bromide kg 42.50 Toluene 4.30 Distillation loss
4 -------------- kg -------- Distillation Residue
13. Used for II nd crop recovery
5 ------------------ kg ---------- Toluene 15 Product drying loss
Total kg 292.50 -------- 292.50 ----------------
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 24
P
+
Br
Mol.Wt 107
+
Toluene PH
Br
Triphenyl Phosphine
Mol.Wt 262
Ethyl Bromide Ethyl Triphenyl Phosphonium Bromide
Mol.Wt 371
Route of synthesis for Ethyl Triphenyl Phosponium Bromide
Process Flow Diagram-
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 25
Table No. 2:- Pollution load Ethyl Triphenyl phosphonium Bromide. Effluent in m3, rest all in kgs
Stage Effluent
Solvent Residue
Carbon Hyflow Spent Solvent
Gas Generated
Inorganic Salt
Organic Residue
LCOD HCOD Name Qty
I ------- ------- 13 * ----- ----- ----- ---- ---- -------- ------ M ------ ------ 962.91 ---- ------ ------- ------ ----- -------- -------
D ------- ------- 38.516 ------- ----- ------- ----- ----- ------- -----
*-Solvent Residue is recycled for product recovery and hence not HW. M-Pollution Load per Month, D- Pollution Load per Day. No pressure or exothermic reaction or runaway reaction No gas is generated during the course of Reaction.
Table No.3:- Solvent Balance of Ethyl Triphenyl phosphonium Bromide
Sr.No/ Stage
Qty in Kg/Day Name of the
solvent
Solvent Used
Recovered [Distilled]
Fugitive loss
To waste Water
Residue
Product drying
loss
Spent Solvent
Fresh Make
Up
I Toluene 444 370.59 ------ Nil 38.48 44.40 ------ 73.408
Table No. 4 :- Matrix showing Molecular weight, Moles, molar ratio and consumption
The below figures of the respective raw material are representative of a batch.
Name of Key
RM/Solvent
Details Mol.Wt
Qty kg
Moles
Molar
Ratio
Existing Consumptio
n
Proposed Consumptio
n
Net Consumptio
n Toluene Solvent ----- ------ ----- ---- -------- 24.80 24.80
Triphenyl Phosphine
Raw Material
162 100 0.381 1 ---------- 100 100
Ethyl Bromide
Raw material
108.97
42.50
0.390 1.023 ------------- 42.50 42.50
Note: -Solvents is in terms of volume and not based on mole ratio.
Key Raw materials are considered as they are involved to build the desired molecule.
Other product details and manufacturing process is attached as an Annexure.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 26
3.5 Plant Machinery and Equipment’s-
Item No. Description Capacity Number
A Mechanical
1. Stainless Steel Reactor 2 KL 1 2. Stainless Steel Reactor 3 KL 1 3. Glass Lined Jacketed Flange Type Reactor 2 KL 1 3.1 MS Glass lined double jacketedcondenser 6 SQM 1 3.2 MS Glass lined Unjacketed Column Section NA 1 4. Centrifuge SS 316 with control panel and VFD 36 inch 1 5. Tray Dryer 48 trays 1 6. Multimill 3HP Non-GMP Model with VFD NA 1 7. Scrubber NA 1 8. Steam boiler 600 kg/hr 1 9. Chimney NA 1 10. Vacuum pump NA 1 11. Cooling tower with FRP Basin 100 TR 1 12. Chilling plant 10 TR 1 13. Condenser 10 m2 1 14. Condenser 6 m2 2 15. Condenser 4 m2 1 16. Receiver 300 liter 1 17. Receiver 200 liter 1 18. Hammer Coated Receiver 100 liter 1 19. 150 NB Column NA 1 20. 200 NB Column NA 1 21. Pipe Line NA 1 22. Hydrogenator 500 lit 1 B Instrumentation
1. pH meter 0 -14 pH 1 2. TDS meter NA 1 3. Analytical balance 1 – 200 gm 1 4. Moisture balance NA 1 5. Balance 300 Kg 1
C Zero discharge liquid plant 250 lit/hr 1
3.6 Technology Selection
1. The technology of the products is developed by the promoters and well established andhence is
aware about the sensitive points that need careful attention in advance.
2. The products are produced using a novel & eco-friendly process.
3. The process is cost effective, safe and environment friendly.
4. Solvents used are recoverable, and are so recovered.
5. The conversion to desired product is 100 % and no side reaction takes place
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 27
3.7 Raw Material for finished Product
The basic raw material for these products details are given with all reactants, solvents and work up
support chemicals, collectively for the year.
Source for Raw Material Procurement: Raw Material is easily available in the local market; some
of the raw materials will be procured from the International Market.
Mode of Transport of Raw Materials: Few of the raw materials will be transported locally like
Nearby Aurangabad, Mumbai, Pune, Hyderabad etc. and few will be imported (if required) from the
International Market.
Storage at the site: Raw materials will be stored in Storage Yard at the project site.
3.8 Availability of Resources (Water, Energy/Power Requirement)
Power: The power requirement for proposed project is 150 KVA.
Water Requirement
Total water requirement for the project shall be 42 CMD and shall be provided by MIDC,
Paithan. The treated water shall be used for plantation. The total water balance for proposed
project is presented in the table below;
Table No.3.4 :- Detailed Water Balance
Sr.
No User source Input Loss
Effluent CMD Remark
LCOD HCOD
1. Steam Boiler 10 10 ---- ------ Condensate Recycled, Bolier
blow down to ETP
2. Softener Regeneration 2 --- 2 - TO ETP for treatment
3. Manufacturing Process 10.0 0.50 --- 9.50 Evaporation
4. Cooling Tower Process 5 4 1 ----- Evaporation loss,
5. Cooling Tower Vacuum
pump
0.50 0.50 ------ ------- ---
7. Vacuum Pump process 0.5 0.30 0.2 ------ ---
8. Q.C. Lab 0.5 0.1 0.2 0.2 ---
9. Utensil Washing 0.5 0.2 0..3 - ---
10. Machinery Washing 3 0.2 2.0 0.8 ---
11. Floor Cleaning 0.5 0.1 0.4 - ---
12. Centrifuge Bag Washing 0.5 0.1 0.4 - ---
13 Scrubber 2.0 0.50 1.5 ----- --------------------------------
14 Domestic 2 0.2 1.8 - To agriculture and gardening.
15. Gardening 5 5 ---- ------- For Green Belt
Total 42 21.70 9.80 42 ----------------
Total water consumption:/ CMD 42
Loss due to consumption and evaporation: 21.70
Domestic/CMD 1.80
Process / CMD 9.50 -LCOD, 1.0 HCOD
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 28
R&D Process/ CMD 0.2 - LCOD
Other / CMD 9.80 LCOD
Total Effluent / CMD 20.50
Manpower: During Operation Phase total man power available with industry is around 10 nos.
including skilled and non-skilled.
Fuel for Boiler: Capacity of proposed boiler is 0.6 MT /hr. (Fuel required – Coal/ Briquette/
Firewood)
DG Set: DG set of capacity 80 KVA is proposed and it is used as a standby.
3.9 Quantity of waste to be generated Non-Hazardous waste details-
Sr. No. Type of waste
Quantity Kg/month
Method of Disposal
1. Canteen waste 20 Kg/month Send to Authorised vendor 2. Packaging waste 30 Kg/month Send to Authorised vendor 3. Office waste 5 Kg/Month Send to Authorised vendor 4. Polythene bag 20 Kg/Month Send to Authorised vendor 5. Broken glass 5 Kg/ Month Send to Authorised vendor 6. Corrugated boxes 100Kg/ Month Send to Authorised vendor 7 M.S. scrap 100 Kg/Month Send to Authorised vendor 8. S.S. Scrap 150Kg/ Month Send to Authorised vendor 9. Boiler Ash 250 Kg/d Sell to brick manufacturing
unit Hazardous waste details -
Sr. No. Type of waste Category Quantity Kg/month
Method of Disposal
1. Off specification products 28.4 50.0 Regular Recycler /Cement Industry
2. Discarded containers Barrels, used for HW chemicals
33.1 200.0 Sale to authorised recycler
3. Spent oil/waste/process/residues containing oil etc
5.1/5.2 50.0
Sale to authorised recycler, re-processor /cement industry/ CHWTSDF
4. ETP Sludge 34.20 50.0 CHWTSDF 5. Manufacturing 28.1 20 CHWTSDF
6. Manufacturing- Spent solvent
28.6 168.0
Sale to authorised recycler, Re-processor, Cement industry
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 29
7. Solvent Residue 20.30 269.2 CHWTSDF 8. MEE Salt 34.20 50.0 CHWTSDF 9. Carbon/ Hyflow 28.3 24.96 CHWTSDF
Hazardous waste generation due to R&D product- i. Solvent residue 20.30 50.0 CHWTSDF ii. ETP sludge 34.20 20.0 CHWTSDF iii. Spent Solvent 28.6 50 CHWTSDF
3.10 Reuse/ Recycle/ Recovery Systems proposed along with Details
1. Sewage will be treated in septic tank followed by soak pit. Overflow of soak pit shall be used for
green belt.
2. The quantity of effluent generated will be treated in Effluent treatment plant, in following stages;
3. Low polluting stream effluent will be treated in ETP (involving Primary Treatment, 2 stages
Secondary Treatment and Tertiary Treatment) and will be used for landscaping
4. High polluting stream effluent will be treated in a system comprising of Solvent stripper, MEE.
5. The treated effluent shall be used for landscaping.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 30
Chapter 04
Site Analysis
4.1 Connectivity
This project site is at A-106/1, MIDC Paithan Industrial Area, Village: Mudhalwadi, Taluka: Paithan,
Aurangabad, Maharashtra. Pin Code: 431148. It is well connected by road, railway and airport.
Nearest highway is SH-30. The site is 36.70 km from Aurangabad Airport and 37.6 km (aerial) from
Aurangabad Railway Station. The land and infrastructure are made available by MIDC. There is
good road connectivity to Aurangabad, Ahmednagar other cities by road network. The raw material
is easily available through the easy transport via road connectivity. With all this consideration, this
site was ranked first and adopted.
4.2 Land form, Land use and Land ownership:
The total plot area is 2499 sqm. The proposed project is located at Paithan, MIDC area. Landuse is
for industrial activity only and land ownership is on MIDC & taken by proponent.
Annexure Ishow the distance between project site and Jayakwadi Dam.
Land Form: Land is on plain contour, it is flat terrain.
Land Ownership: Land ownership is with project proponents.
Existing Land use Pattern: The Land is reserved for Industrial use.
Existing Infrastructure: Project site is having existing MIDC’s infrastructure such as road,water
supply, electricity etc.
4.3 Topography
Marathwada region comprising of eight districts, viz. Aurangabad, Beed, Hingoli, Jalna,Latur,
Nanded, Osmanabad and Parbhani. The location of Marathwada is on 70 5’ – 78 5’ E longitude and
17 5’ – 20 5’ N latitude form the part of the vast Deccan plateau all of India and is one of the six
divisions of Maharashtra State.
The total area of Marathwada region is of 64,813 km. and is bounded by the Vidarbha regionon the
North, by Andhra Pradesh on the East and Southeast, by Karnataka on the South and by Western
Maharashtra on the West. The entire region is situated at an average height of about 300-650 m.
above Mean Sea Level gradually sloping from West to East, and istraversed by hill ranges
origination from the Sahyadris in the West and the Satpudas in the North.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 31
4.4 Soil Classification
The major part of the Aurangabad district is dominated by black cotton soil or ‘Regur’formed by the
weathering of Deccan Trap Basalt. It is rich in plant nutrients such as lime, magnesia, iron and
alkalies on which cotton and dry crops like Jowar, Bazra and tur etc.flourish. It swells and becomes
sticky on watering while on drying it contracts and develops many cracks. The soil varies both in
texture and depth. In northern portion of the district the soils are shallow and relatively poor while
in south they become deep and fairly rich in nutrients.
4.5 Climate data from secondary sources
Aurangabad has a semiarid climate under the Köppen climate classification.
Temperature: Annual mean temperature in Aurangabad range from 17 to 33 °C, with the most
comfortable time to visit in the winter October to February. The highest maximum temperature
ever recorded was 46 °C (114 °F) on 25 May 1905. The lowest recorded temperature was 2 °C (36
°F) on 2 February 1911. In the cold season, the district is sometimes affected by cold waves in
association with the eastward passage of western disturbances across north India, when the
minimum temperature may drop down to about 2 °C to 4 °C (35.6 °F to 39.2 °F).
Rainfall: Most of the rainfall occurs in the monsoon season from June to September.
Thunderstorms occur between November to April. Average annual rainfall is 710 mm. The city is
often cloudy during the monsoon season and the cloud cover may remain together for days. The
daily maximum temperature in the city often drops to around 22 °C due to the cloud cover and
heavy rains.
4.6 Social Infrastructure available
Many large- and small-scale industrial units have been established in MIDC is situated in
thecommand area of MudhalwadiGrampanchayat. There are facilitates for the workers to staynear
MIDC. Aurangabad airport is located 36.70km, State highway SH-30 from project site at 0.7 km,
Railway Station is Aurangabad Railway Station at 37.06 Km. Fire station, Hospitals, Police station,
Fire station & tourist place (Paithan) is at accessible distance from the project site.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 32
Chapter 5
Planning Brief
5.1 Planning Concept
Proposed plant will be at M/s. Quantinental Pharmachem Pvt. Ltd., MIDC Paithan. All basic
infrastructure facilities will be provided to workers and office staff & also ensure the social
development work under its Corporate Social Responsibility (CSR). All statutory requirements will
befulfill before commissioning and while operation of the plant.
5.2 Facilities
This site is inside the existing MIDC and means safe transportation, less need of utilities, less
constructing buildings and roads, less fuel, less water with optimization of infrastructure.
Government MIDC has provided all infrastructures like electrical power, continuous water supply,
internal road network, external approach road, and networking.
5.3 Land use Planning
Land is already developed for Industrial purpose. Easting Area break-up are like fooling
Total area required: - 2499 Sq.Mt Built up area for Factory shed: - 243.04 Sq.Mt Built up area for storage: - 236.04 Sq.Mt Built up area for office: - 13.36 Sq.Mt Open Space for utility: - 65.73 Sq.Mt` Other : - Open Land 1940.83 Sq.Mt
5.4 Population Projection
Total 10 persons are required for proposed unit. Local people will be preferred for jobs based on
their educational qualification, experience and capabilities.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 33
Chapter 6
Proposed Infrastructure
6.1 Industrial area
M/s Quantinental Pharmachem Private Limited “Proposed Active Pharmaceutical Ingredients
(APIs) and API Intermediates Manufacturing” is located is in Paithan MIDC.
6.2 Residential Area
No residential area has been proposed for the project. Facility will be provided for emergency
workers only, but no one will stay in the premises.
6.3 Green Belt
Industry proposed to develop nearly 1940 sqm for green belt development by planting various
types of trees and area has also been beautified with plantation of ornamental trees
6.4 Connectivity
As the proposed site is in Paithan MIDC, it is well connected through highway & internal roads. No
new roads are proposed.
6.5 Water Management:
The water requirement is about 85.5 m3/day for Domestic, cooling, boiler and greenery and
processes. The source of water is already available MIDC and the same is adequate and satisfactory.
Project proponent not encroaching on anybody’s water source.
6.6 Sewage System/ ETP
Sewage will be treated in septic tank followed by soak pit. Overflow of soak pit shall be used for
green belt
The quantity of effluent generated will be treated in Effluent treatment plant, in following stages;
Low polluting stream effluent will be treated in ETP (involving Primary Treatment, 2 stages
Secondary Treatment and Tertiary Treatment). Treated effluent will be used for landscaping.
High polluting stream effluent will be treated in a system comprising of Solvent stripper, MEE.
Treatment Scheme-
This plant has been designed as zero liquid discharge plant. The system has been designed as single
effect evaporation system with thermo Vapour compression.
This plant comprises of single effect evaporator along with efficient Vapour-liquid separation
system. Feed will be preheated & then will enter into Evaporator. Evaporator will be provided with
thermo Vapour compression system. Concentrated effluent shall be transferred from evaporator by
circulation cum transfer pump.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 34
Vapors from vapor liquid separator will be sent to surface condenser. This condenser shall be
cooled by cooling water. Process Condensate from evaporator as well as surface condenser shall be
taken out from surface condenser by Process Condensate Pump. Condensate generated will be
treated in Reverse osmosis plant & can be reused in the system or for tree plantation purpose.
Concentrated effluent will be dried in agitated thin film dryer to dry it further & can be disposed
further.
The system will operate under vacuum. Vacuum will be applied by using water ring vacuum pump
to remove non-condensable from the system.
System will be supplied with required sufficient panel & automation.
6.7 Air Pollution
The air pollution is mainly from emissions of air pollutants from the boiler stacks and DG set. Very
little emission from fugitive sources is also predicted. Total power requirement for proposed plant
is 150 KVA which is sourced from Maharashtra State Electricity Distribution Company Limited
(MSEDCL). The other energy source is proposed solid fuel fired boiler of 0.6 MT/day. DG SET will be
80 KVA Capacity (fuel requires HSD) is used as a stand-by source of electricity. Cyclone dust
collector is proposed to combat the emissions from the boilers before releasing into atmosphere
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 35
through a stack. Very little emission from fugitive sources is also predicted. The stack heights
areprovided as per the guidelines of CPCB.
6.8 Solid Waste Management
The main solid waste from this factory will be (a) non-hazardous and (b) hazardous from process.
a. Non-hazardous waste:
Non-Hazardous waste details- Sr. No. Type of waste Quantity Kg/month 1. Canteen waste 20 Kg/month 2. Packaging waste 30 Kg/month 3. Office waste 5 Kg/Month 4. Polythene bag 20 Kg/Month 5. Broken glass 5 Kg/ Month 6. Corrugated boxes 100Kg/ Month 7 M.S. scrap 100 Kg/Month 8. S.S. Scrap 150Kg/ Month 9. Boiler Ash 250 Kg/d Nonhazardous waste will be segregated as recyclable/ saleable.
Waste minimization at all levels for discarded products, empty containers, packing, surplus,
unloading spillages and fugitives.
The plant will produce very less amount of scrap material. All these will however be stored
carefully on raised platform, with dwarf toe-walls all around and an overhead roof. The contents
will not be stored in the factory for more than a fortnight.
b. Hazardous Waste-
Sr. No. Type of waste Category Quantity Kg/month
Method of Disposal
1. Off specification products 28.4 50.0 Regular Recycler /Cement Industry
2. Discarded containers Barrels, used for HW chemicals
33.1 200.0 Sale to authorised recycler
3. Spent oil/waste/process/residues containing oil etc
5.1/5.2 50.0
Sale to authorised recycler, re-processor /cement industry/ CHWTSDF
4. ETP Sludge 34.20 50.0 CHWTSDF 5. Manufacturing 28.1 20 CHWTSDF
6. Manufacturing- Spent solvent
28.6 168.0 Sale to authorised recycler, Re-processor, Cement industry
7. Solvent Residue 20.30 269.2 CHWTSDF
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 36
8. MEE Salt 34.20 50.0 CHWTSDF 9. Carbon/ Hyflow 28.3 24.96 CHWTSDF
Hazardous waste generation due to R&D product- iv. Solvent residue 20.30 50.0 CHWTSDF v. ETP sludge 34.20 20.0 CHWTSDF vi. Spent Solvent 28.6 50 CHWTSDF
6.9 Power Requirement & Supply/ Source
Power requirement of proposed plant is 150 KVA and will be supplied by MSEDCL. DG set
of capacity 80 KVA is also proposed for emergency backup.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 37
Chapter 07 Rehabilitation and Resettlement (R & R Plan)
7.1 Policy to be adopted
The project site is located in MIDC area, hence there is no any kind of activity of Rehabilitation and
Resettlement has to be carried out.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 38
Chapter 08
Project Schedule & Cost Estimates
8.1 Time schedule of the Project
M/s Quantinental Pharmachem Pvt. Ltd. is wants to commence their project within 6 to 8
Months after getting all relevant permissions and clearances.
8.2 Estimated project cost
Estimated Project Cost for the project is 404.96 Lacs;
Table 8.1: Project cost
Sr. No. Fixed Assets Proposed Amount Rs. In Lakhs
1. Land and land development 25.09
2. Building premises 78.23 3. Plant & Machinery/Equipment 170.83
5. EMP Cost (including green belt) 94.5 6. CSR 10.00
7. Other 26.31 Total 404.96
Table 8.2 Environment Management Cost
Sr. No.
Description Capital Cost (Rs. in Lakhs)
Recurring Cost per annum (Rs. in Lakhs)
1. Air Pollution Control system 21.00 1.05 2. Water Pollution Control 65.0 4.0 3. Environment monitoring and Management 1.5 0.40 4. Rain water Harvesting 1.00 0.10 5. Occupational Health 1.00 0.20 6. Green Belt 1.00 0.82 7. Solid waste management 3.00 0.50 8. Energy Saving Devices and Solar Heating System 1.00 0.10 Total 94.5 7.17
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 39
Chapter 9
Analysis of Proposal
9.1 Financial and Social Benefits
M/s Quantinental Pharmachem Pvt. Ltd. will create direct & indirect employment opportunities
to the people residing at surrounding region. The management also trying to recruit the locals by
giving them in plant training and making them permanent employee.
Different types of people are being recruited based on the basic qualification as skilled, unskilled or
semiskilled.
Considering financial point of view, proposed project helps to generated Additional government
revenues from taxes, duties and other fees. Additional benefit of the project also includes
considerable growth of the industrial and commercial activities in the state.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 40
Annexure I:
Wild life letter
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 41
Annexure-II
Google Image
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 42
Annexure-III
Toposheet Showing Location of Project Site from Jayakwadi Dam
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 43
Annexure-IV
Proposed Master Layout Plan
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 44
Annexure-VI MIDC
Layout
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 45
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 46
Annexure-V
Detailed Manufacturing Process of the remaining products
(Product No. 4 to Product No. 23)
4. NAME OF PRODUCT: FLUCONAZOLE
Brief description of the Process: -
Crude Fluconazole is charged in water and stirred to get a homogeneous solution. To this solution
30 % hydrochloric acid is added to get a clear solution at ambient temperature. Carbon and hyflow
is added and reaction mass is stirred for 10-20 minutes. The reaction mass is filtered to separate
carbon,hyflow. To the clear solution 25 % ammonia solution is added to precipitate Fluconazole.
The product formed is centrifuge and washed with water and spin dried. The wet product is dried
in tray dryer at 100 0c to dry and pure fluconazole.
Route of Synthesis
Crude Fluconazole
1. HCl, Ammonia Crabon, Hyflow
F
F
CH2
OH
H2C NN
N
NN
N
Fluconazole
Molecular Wt. 306.7
+ NH4CL + H20
Qty/Month 475.00kg.
Batch Output 475 kg
No of Batches/ Month 1
No of working days 25
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 47
Process Flow diagram-
Table no. 1 :- Input and output and mass Balance
Input UOM Qty Output Qty Remark
Crude FLC kg 583 Product 475 Pur Fluconazole
HCl 30 % kg 570 Aq.Effluent HCOD 6458
Ammonia 25% kg 372 Carbon 48 TO CHWTSDF
Carbon kg 48 Hyflow 19 TO CHWTSDF
Hyflow kg 19 Ammoium Chloride
292 Salt formed in the purification process
Water kg 5700 ------ ------- -------
Total kg 7292 Total 7292 ----------------
Table no. 2:- Pollution load. Effluent in M3, Rest all in Kgs
Stage Effluent in Lit
Solvent Residue
in kg
Carbon In kg
Hyflow In kg
Spent Solvent
In kg
Gas generated Qty kg
Inorganic Salt
In kg
Organic Residue In kg LCOD HCOD Name Qty
I
I ------ 6750 ----------- ------- ------- ----- Nil ----- --------- ---------
M ------ 6750 ---- 48 19 ------- ------ ----- 292* --- D ------ 270 ----- 1.92 0.76 ----- ---- --- 11.68 ------
* In Organic Salt is in effluent in dissolved state. No pressure or exothermic reaction. Toxic and hazardous raw materials Gas is generated during the process of purification or manufacturing process.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 48
Table no. 3:- Solvent Balance of Fluconazole.
Sr.No/ Stage
Qty in Kg/Day Name of the solvent
Solvent Used
Recovered [Distilled]
Fugitive loss
Distillation Process loss
To waste Water
Distillation Residue
Product drying loss
Spent Solvent
Fresh Make Up
I
Ammonia
Solution
372 --------- ------ ------- 372 ------- ----- ---- 372
Table no. 4 :- Matrix showing Molecular weight, Moles, molar ratio and consumption
Name of Key RM/ Solvent
Details Mol.Wt Qty kg
Moles Molar Ratio
Existing Consumption
Proposed Consumptio
n
Net Consumption
Crude FLC
Raw material
30.6 583 0.524 1 ------- 583 583
Ammonia Reagent 17 93 5.40 10.10 -------------- 372 372 Wtaer Solvent ---- 5700 ---- ---- -------- 5700 5700
Note: - Solvents is in terms of volume and not based on mole ratio. Key Raw materials are considered as they are involved to build the desired molecule
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 49
5. Name of the Product- LINEZOLID
Qty/Month 94.00kg.
Batch Output 94 kg
No of Batches/ Month 1
No of working days 25
Brief Manufacturing Process-
Crude Linezolid is charged in a SS Reactor having previously charged Isopropanol. The reaction
mixture is heated to 40-50 0c to get a clear solution. To the hot clear solution, carbon and hyflow is
charged and the reaction mixture is further heated to reflux temperature and maintained for 1-2
hrs. The hot reaction mass is filtered through sparkler pressure filter. The filtrate is collected in a
clean SS Reactor. Isopropanol is distilled to 50 % of input and then cooled to ambient and further
cooled to 0-5 0c and maintained for 1 hr. The reaction mass is centrifuged and spin dried. Wet pure
LINEZOLID is dried in tray dryer to get dry LINEZOLID. Mother liquor is recycled.
Table No 1:- Input and output and mass Balance
Input UOM Qty Output Qty Remark
Crude Linezolid kg 100 Linezolid 94 Pure Linezolid
Isopropanol kg 300 Isopropanol 150 Rec and recycled
Carbon Kg 10 Carbon 10 To- CHWTSDF
Hyflow kg 5 Hyflow 5 To CHWTSDF
-------------- kg ------- Mother liquor 156 Recycled
Total kg 415 Total 415 --------------
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 50
Route of Synthesis
O
N
F NO
NHO
N-((3-(3-fluoro-4-morpholinophenyl)-2-methyleneoxazolidin-5-yl)methyl)acetamide
Mol.Wt 335.37
O
N
F NO
NHO
N-((3-(3-fluoro-4-morpholinophenyl)-2-methyleneoxazolidin-5-yl)methyl)acetamide
1. Isopropanol2. Carbon3.Hyflow
Mol.Wt 335.37
Crude Linezolid
Process Flow Diagram-
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 51
Table No 2:- Pollution load. Effluent in m3, Rest all figs in kg.
Stage Effluent in lit
Solvent
Residue
Carbon Hyflow Spent
Solvent
Gas
Generated
Inorganic
Salt
Organic
Residue
LCOD HCOD Name Qty
I ------ ------- ----- 10 05 ----- ------ ----- ------- --------
M ------- --------- ----- 10 05 ---- ----- ---- ---- ----
D -------- ------ ------- --0.40 0,20 ----- ----- ---- ----- -----------
M- Pollution load per month,D- Pollution load per day.
No gas is produced or generated during the reaction processing.
The reaction is not exothermic or run away or pressure.
No toxic raw material is used in manufacturing process of Linezolid.
6. Product Name- TELMISARTAN
Qty/Month 400.00kg.
Batch Output 100 kg
No of Batches/ Month 4
No of working days 25
Brief Manufacturing Process-
4- Methyl –Biphenyl -2 Craboxylate is charged in solvent Ethyleen di chlorided at ambient
temperature. The reaction mass is stirred and a solution od sodium carbonate is added at ambient.
To this reaction mass N-Bromo succinamide is added and reaction mass is stirred for 1-2 hrs and
settled.
The aqueous layer is separated and subjected for succinamide recover and let to ETP for treatment.
The EDC layer containing Bromo derivative is distilled under vacuum completely. The reaction
mass is cooled to ambient and Acetone is added to the reaction mass and stirred for 10-20 minutes.
To this reaction mass is added water, pottasium hydroxide, TBAB and Benzimidazole. The total
reaction mass is heated to reflux and maintained for 4-5 hrs till completion of reaction. The
completion of reaction mass is ensured on TLC. If the reaction is complete, the reaction mass is
cooled to ambient and centrifuge. The product is washed with water, spin dried and unloaded and
wet cake at this stage is used for next stage. The wet product is charged in methanol and NaOH
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 52
solution and heated to reflux and maintained for 2 hrs. Carbon is added and refluxed further for
20-30 minutes and filtered. The clear filtrate is added acetic acid to precipitate Telmisartan. The
reaction mass is cooled to ambient and then to 0-5 0c and centrifuged and washed with water to get
acid free, spin dried and unloaded. The wet cake is dried in Tray dryer to get dry TELMISARTAN.
Table No 1.:- Input and output and mass Balance
Input UOM Qty Output Qty Remark
4-Methyl Bi Phenyl-
Carboxylate
kg 98 Telmisartan 100 Final Product
EDC kg 590 EDC 580 Recovered and recycle
Sodium Crabonate kg 15 EDC 10 Distillation loss
N-Bromo Siccinamdie kg 85 Succinamide 44.20 Recovered and sale
Acetone kg 200 Spent Ml-Acetone 850 Sale to Recycler
KOH kg 92 Spent Ml
Methanol
1164,80
Sale to Recycler
Benzimidazole kg 100 Carbon 4 To CHWTSDF
TBAB kg 10 Hyflow 2 To CHWTSDF
Methanol kg 900 Aq.Effluent LCOD 800 -To ETP for treatment
NaOH kg 36 Drying loss 40 Evaporation loss during
product drying operation
Carbon kg 4 -------------- ------ -----------------
Hyflow kg 2 ------------ ------- ----------------------
A cetic acid kg 125 --------------- ------ -------------------------
Water kg 1250 --------------- ------ -----------------------
Total kg 3595 Total 3595 ----------------------
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 53
Route of Synthesis
COOCH3EDC , NaHCO3
N Br
O
O
COOCH3
4-Methyl-Biphenyl-Carboxylate
Mol.Wt 226.27
1-bromopyrrolidine-2,5-dione
Mol.Wt 178
Br
Bromo Methyl Biphenyl Carboxylate
Mol.Wt 306
COOCH3
Br
Bromo Methyl Biphenyl Carboxylate
Mol.Wt 306
+N
N
NH
N
1-methyl-2-(4-methyl-2-propyl-1H-benzo[d]imidazol-6-yl)-1H-benzo[d]imidazole
Mol.Wt 304..39
1.Acetone, KOH,TBAB
2. methanol, NaOH, Carbon,Hyflow
3,Acetic acid,Water
N
N
N
N
HOOC
TELMISARTAN Mol.Wt 514.617
NH
O
O
+
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 54
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 55
Table No 2:-Pollution load. Effluent in m3, Rest all figs in kg.
Stage Effluent in lit
Solvent
Residue
Carbon Hyflow Spent
Solvent
Gas Generated
Inorganic
Salt
Organic
Residue LCOD HCOD Name Qty
I 0.800 ------ ----- 4 2 2014.80 ------ ----- ------- --------
M 3.200 ------- ----- 16 8 8059.20 ---- ----
D 0.128 ------- ----- ---- 322.37 ----- ---- ----- -----
M- Pollution load per month D- Pollution load per day.
1. No gas is produced or generated during the reaction processing.
2. The reaction is not exothermic or run away or pressure.
3. Toxic and hazardous raw material used 1. Toluene 2. Sulphuric acid.
Table No 2: -Solvent balance of Telmisartan
Sr.No/
Stage
Qty in Kg/Day
Name of
the
solvent
Qty
Used
Recovered
[Distilled]
Fugitive
loss
Distillation
Process
loss
To
waste
Water
Distillation
Residue
Product
drying
loss
Spent
Solvent
Fresh
Make
Up
I EDC 16 Nil Nil Nil 16 Nil Nil Nil 16
I Acetone 58.48 46.72 ------- 0.8 0.8 8 ----- ------ 1.12
Methanol 24 --------- 0.16 ------ 23.84 ---- --- ---- 24
Table No 3:- Matrix showing Molecular weight, Moles, molar ratio and consumption
The below figures of the respective raw material are representative of a batch.
Name of
Key RM
Details Mol.Wt Qty
kg
Moles Molar
Ratio
Existing Consumption
Proposed
Consumption
Net
Consumption
RM I Raw
material
226.37 98 0.434 1 ------------ 98 98
RM II Raw
material
304 100 0.329 0.75 -------------- 100 100
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 56
N-Bromo
Succinamide
Raw
material
178 85 .477 1.10 ------------ 85 85
EDC Solvent ---- 590 ----- ---- ------- 10 10
Acetone Solvent ----- 230 ----- ----- ------ 230 230
TBAB Catalyst 322 10 0.0310 0.07 ------- 10 10
KOH Reactant 56 92 1.64 3.785 ---------- 92 92
NaOH Recant
Methanol Solvent ----- 900 ---- ----- ------ 900 900
Note: - Solvents is in terms of volume and not based on mole ratio.
Key Raw materials are considered as they are involved to build the desired molecule.
7. Product Name- TETRA BUTYL AMMONIUM BROMIDE
Qty/Month 130 Kg
Batch Output 130 kg
No of Batches/ Month 1
No of working days 25
Brief manufacturing process-
Acetonitrile is charged in clean SS Reactor, followed by addition of N-Butyl Amine. The reaction
mass is stirred for 15-20 minutes and heated to reflux. N-Butyl Bromide is added slowly keeping
the temperature of the reaction mass to 65-70. The reflux is maintained for 36 hrs. Acetonitrile is
recovered completely under vacuum and Ethyl acetate is added to the reaction mass. The reaction
mass is cooled to 0-5 0c and centrifuged. The wet cake is washed with ethyl acetate. Mother liquor
is collected for recovery of ethyl acetate and recycling. Recovered Acetonitrile is stored and
recycled for next successive batches.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 57
Route of Synthesis
Table No. 1 :- Input, output and Mass balance.
No Input Name UOM Qty Output name Qty Remark
1 Tri-n-Butyl Amine kg 100 Product TBAB 130 Product
2 N-Butyl Bromide kg 105 Acetonitrile/ N-
Butyl Bromide and
Tributyl amine
Mixture
80 Recovered and use
3 Acetonitrile kg 34 Acetonitrile 4 Distillation loss
4 Ethyl acetate kg 107 Ethyl acetate 91 Recovery and use
5 ---------------------- kg -------- Ethyl, acetate 6 Distillation loss
6 --------------------- kg ---- Product drying
loss
10 Drying Loss
--- ------------------ kg ----- Solvent Residue 25 CHWTSDF
--- Total kg 346 Total 346 ---------------
TBAB- Tetra Butyl Ammonium Bromide.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 58
Process flow diagram-
Table No.2 :-Pollution load. Effluent in m3, rest all figs in kg.
Stage Effluent in M3
Solvent
Residue
Carbon Hyflow Spent
Solvent
Gas
Generated
Inorganic
Salt
Organic
Residue
LCOD HCOD Name Qty
I ------ ----- 25* Nil Nil --Nil-- Nil Nil Nil -------
M ------- ------ 25* Nil Nil Nil Nil Nil Nil ------
D -------- ------ 1.0* Nil Nil Nil Nil Nil Nil -------
* Solvent distillation residue is recycled as II nd crop and hence no HW
4. No gas is produced or generated during the reaction processing.
5. The reaction is not exothermic or run away or pressure.
6. Toxic and hazardous raw material used 1. N- Butyl Amine and N-Butyl Bromide.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 59
Table No.3 :- Solvent Balance of TBAB
Sr.No/
Stage
Qty in Kg/Day
Name of the
solvent
Solvent
Used
Recovered
[Distilled]
Fugitive
loss
To
waste
Water
Residue
Product
drying
loss
Spent
Solvent
Fresh
Make
Up
I Acetonitrile 34 12 ------ ------ 25 ----- ------ 22
I Ethyl acetate 107 91 ----- ----- 10 ----- 16
Table No. 4: - Matrix showing Molecular weight, Moles, molar ratio and consumption
The below figures of the respective raw material are representative of a batch. Name of Key
RM/Solvent
Details Mol.Wt Qty
kg
Moles Molar
Ratio
Existing
Consumption
Proposed
Consumption
Net
Consumption
Acetonitrile Solvnet ---- 34 ----- ---- -------- 22 22
Ethyl Acetate Solvent ---- -91 ----- ---- --------- 16 16
N-Butyl
amine
Raw
material
185.36 100 0.539 1 ------- 100 100
N-Butyl
Bromide
Raw
Material
137.02 105 0.766 1.421 -------- 105 105
Note: - Solvents is in terms of volume and not based on mole ratio.
Key Raw materials are considered as they are involved to build the desired molecule
.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 60
8. Product Name- Glimepiride
Qty/Month 150.00kg. Batch Output 150 kg No of Batches/ Month 1 No of working days 25
Brief Description process: - Stage I
Stage I:- 3-Ethyl-4 methyl 1-H pyrazole and 2- Phenylethyl isocyanate, are condensed in
presence of methanol as solvent at high temperature. The resultant product as stage I is isolated by
centrifuging. The wet product is washed with methanol and spin dried. Mother liquor is recycled to
successive batches.
Route of synthesis Glimepiride stage I
Process Flow diagram-
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 61
Table No: - 1 Stage I:-Input, Output and Mass Balance.
Sr. No.
Input UOM Qty Output Qty Remark
001 3-Ethyl-4 Methyl 2-Oxo Pyrroline
kg 70 Stage I product
130 Intermediate Glimepride
002 Phenyl Ethyl Ioscynate
kg 100 Methanol- 10 40
Distillation loss Ml recycled .
003 Methanol kg 160 Methanol 130 Recovery and use ----- -------------------- ----- ------ Methanol 20 Drying loss ----- Total kg 330- Total 330 -------------------- Stage I--- No pollution load. The reaction is dry fusion reaction and Mother Liquor is recycled
to next batch.
Brief Description of the process stage II and III-Chlorosulphonation and amidation.
Stage is I added in chlorosulphonic acid at low temperature. After complete addition, the
reaction mass is digested for 4-5 hrs and then quenched in ice water. The product is centrifuged
and washed with chilled water till the PH is neutral. The wet product is used for amidation stage.
Stage II is added in ethyl acetate in SS Reactor at ambient temperature. The reaction mass is stirred
for 20-30 minutes and slowly 20 % ammonia solution is added under stirring at ambient
temperature. After complete addition of the addition of ammonia solution, tye reaction mass is
stirred for 20-30 minutes. The reaction mass is centrifuged, the wet cake in centrifuge is washed
with water. The mother liquor is collected and ethyl acetate layer is separated. The aqueous layer is
send to ETP,ethyl acetate layer is subjected to distillation. Recovered ethylacetate is reuse. The
residue is discharged in close container and stored for HW disposal. The wet product is dried in
dryer. Dry product at stage III is further used for next stage.
Table No. 2:- Stage II/ III:-Input, Output and Mass Balance.
Sr.No Input UOM Qty Output Qty Remark 001 Stage I [Dry] kg 130 Product 146 Stage III product 002 Chlorosulphonic
acid kg 240 Aq.Effluent
HCOD PH 2 450 ETP for treatment
002 Ice Water kg 100 Ethyl acetate 100 Recovery and reuse 003 20 % Ammonia kg 577 Solvent Residue 18.80 HW Disposal 004 Ethyl acetate kg 105 Aq.Effluent
HCOD/HTDS 813.90 HCOD For Disposal,
Contains salts like Ammonium chloride and sulphate
005 water kg 295 Ethyl acetate 11.30 Solvent loss 006 Stage II kg 158 Water 65 Drying Loss ------ Total kg 1605 Total 1605 ---------------
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 62
Route of Synthesis Stage II/ III
1. Chlorosulphonic acid
2. Water
3. Ethyl acetate
4. 20 % Ammonia.
ClSO3H + H2O+ NH4OH----- NH4Cl+ [NH4]2SO4 + H20
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 63
Stage IV: Glimepiride Crude and Pure
Sulphonamide is condensed with Trans 4-Methyl Isocyanine in presence of Acetone and potassium
carbonate at reflux temperature. The resultant reaction mass is cooled and filtered on notch filter.
The wet solid is washed with acetone. The acetone washing and mother liquor is stored for further
processing. The wet product is charged in water and PH of the reaction mass adjusted to 7.0 with
acetic acid. The reaction mass is stirred at ambient and then centrifuged to get crude Glimepiride.
The crude is purified by using DMF and Methanol solvent.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 64
Table No. 3:- Stage IV:-Input, Output and Mass Balance.
Sr. No
Input UOM Qty Output Qty Remark
1 Sulphonamide Kg 146 Product 160 Crude Final Product 2 Acetone Lit 312 Acetone
Acetone 270 010
Recovery and reuse Distillation loss
3 Potassium Carbonate
Kg 146 Distillation Residue
05 HW Disposal
3 4-Methyl Isocyanate
Kg 76.47 Aq. Effluent HCOD
880.97 To ETP for treatment, contains Ammonium Acetate, acetone
4 Water kg 625 CO2 gas generation
60 Let to atmosphere
5 Acetic acid Kg 55.50 Methanol
425 Recovery and reuse
6 Methanol kg 625 Methanol 170 Spent solvent for sale
7 Carbon kg 7.00 Methanol 05 Distillation loss 8 Hylow kg 2.0 Hyfow 2 HW for disposal 9 ------------------ kg ----- Carbon 7 HW disposal ------ --------------------- kg --------- Methanol 25 Drying loss Total kg 1994.97 Total 1994.97
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 65
Stage V- Purification.
Brief Description of manufacturing process of purification
The crude Glimepiride is charged in DM/ Methanol mixture and heated to 80-90 0c to geta clear
solution. To this clear solution is added carbon and stirred for 20-30 minutes. The hot reaction
mass is filtered through filter to separate the carbon and filtrate is collected in clean Reactor. DMF
and methanol is distilled and recycled. The Reaction is cooled to ambient and water is added to the
reaction mass and stirred. To the water solution is added DIPA, stirred and separated. DIPA solvent
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 66
is sold to authorized recycler. MIBK is added, stirred and settled. The aq layer is separated and
sends to ETP for treatment. The MIBK layer is distilled to recover and recycle. The reaction mass is
cooled and centrifuged and spin dried. The wet cake from centrifuge is dried in tray dryer to get
pure Glimepiride. Centrifuge Ml is send to CHWTSDF as HW.
Table No. 4:- Input, output and mass Balance.
Sr.No Input UOM Qty Output Qty Remark 001 Stage IV GLP Crude Kg 160 Product 150 Pure Glimepride 002 DMF kg 2080 DMF 2000 Rec and Reused 003 Activated Carbon kg 16 DMF 70 Along with Effluent 004 Water kg 320 DMF 10 Process Loss 005 Methanol kg 480 Methanol 400 Rec and reused 006 MIBK kg 640 Methanol 65 Process Loss 007 Di Isopropyl Ether kg 60 Methanol 15 In aq Effluent 008 --------------- kg ---- Carbon 16 To CHWTSDF 009 ----------------- Kg ----- MIBK
MIBK MBK
518 100 20
Recover and Recycle Liquid spent as HW Drying Loss
010 ------------------ kg ----- Di Isopropyl Ether
58 To sale to Recycler
----- ---------------- Kg ---- MIBK 2 Process Loss kg ---- Di Isopropyl
Ether 2 Process Loss
kg ---- Aq. Effluent-HCOD
330 To ETP for Treatment
----- Total kg 3756 Total 3756 -----------
ROUTE of Synthesis Stage V
N
O
NH
OS
NH
O
O
NH
O
CH3
Glimeperide Crude
1. DMF/Methanol2.Carbon3.Water4.DIPE5.MIBK
N
O
NH
OS
NH
O
O
NH
O
CH3
Pure GLP Mol Wt 490
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 67
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 68
Table No.5 :- Cumulative pollution load. [Per day] of Stage I, II, III, IV and V Effluent in m3, rest all in kgs.
Stage Effluent in m3
Solvent Residue
Carbon Hyflow Spent Solvent
Gas Generated
Inorganic Salt
Organic Residue
LCOD HCOD Name Qty
I ----- -------- ---------- ------ -------- ----- --------- ----- ------- ------
II / III
------- 1.263 18.80 ------- -------- ------- ------ ----- ---------- ------
IV ------ 0.880 05 7 2 ----- CO2 55.50 ------- -----
V ---- 0.330 ----- 16 ---- 100 ---- --- --- ----
M --- 2.473 23.80 23 2 100 CO2 55.50 -------- --------
D ---- 0.0989 0.952 0.92 0.08 4.0 CO2 2.22 -------- -------
M- Pollution load per month.
D- Pollution load per month
Table No. 6:- Solvent Balance of Glimepiride
Sr.No/ Stage
Qty in Kg/Day/Month Name of the solvent
Solvent Used
Recovered [Distilled]
Fugitive loss
Distillation Process loss
To waste Water
Distillation Residue
Product drying loss
Spent Solvent
Fresh Make Up
I Methanol 1265 955 --- --- --- --- --- --- 310
II Ethyl Acetate
105 100 ----- 2 3- -18.80 ----- ---- 5
II Water 1340 ---- ----- ---- 1275 ----- 65 ---- 1340
III Acetone 312 270 ----- 10 ------ 5 ---- ----- 42
V DMF 2080 2000 80
VI DIPE 60 58 ---- 2 ---- ---- ---- ---- 2
VII MIBK 640 518 ---- 2 ----- 100 20 ----- 120
DIPE- DI ISOPROYL ETHER,DMF –DIMETHYL FORMAMIDE, MIBK- METHYL ISOBUTYL KETONE
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 69
Table No.7:- Matrix showing Molecular weight, Moles , molar ratio and consumption.
Name of Key
RM/Solvent
Details
Mol.Wt
Qty kg
Moles
Molar
Ratio
Existing Consumpti
on
Proposed Consumpti
on
Net Consumpti
on
Pyrroline Raw materi
al
125 70 0.56 1 --------- -70 70
Phenyl Isocynate
Raw materi
al
147 100 0.68 1.21 ------------ 100 100
Chlorosulphonic acid
Raw materi
al
116.50
240 2.06 1 ------------- 240 240
Ammonia Reagent
17 144.25
--8.48
4.11 ----------- 577 577
Potassium Carbonate
Reagent
138 146 1.05 1 --------- -146 146
Trans-4 Methyl Cyclohexylisocy
nate
Raw materi
al
139 76.47 0.50 0.50- --------- 76.47 76.47
Acetic acid Reagent
---- 55.50 ---- ---- ---------- 55.50 55.50
Methanol Solvent
------ 1265 -------
----- --------- 310 310
Acetone Solvent
----- 312 ----- ---- -------- 42 42
DIPE Solvent
---- 60 ----- --- ----- 60 60
MIBK Solvent
----- 640 ------ ---- ----------- 120 120
Water Solvent
---- 1340 ----- ---- ------- 1340 1340
DMF Solvent
------ 2080 ------ ---- ----- 80 80
Note: - Solvents is in terms of volume and not based on mole ratio.
Key Raw materials are considered as they are involved to build the desired molecule.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 70
9. Name of the Product- TRI-O- Phenyl phosphine
Qty/Month 2 MT.
Batch Output 166 kg
No of Batches/ Month 12
No of working days 25
No of Batches/day 0.480
Brief Manufacturing Process-
Ochloro Toluene is reacted with Magnesium metal in the presence of THF. The Grignard reagent so
prepared is treated with Phosphorus Tri Chloride in toluene. The resultant reaction mass is
quenched in acid water. To the reaction mass is stirred and settled. The aq layer and organic layer is
separated and washed with alike water. The solvent component containing product is treated with
carbon and filtered. The filtrate is subjected for complete solvent recovery. Isopropanol is added
and reaction mass is cooled and chilled and centrifuge to get wet TOTP, which on drying in tray
dryer gives dry TOTP. The distillate is treated with ferrous sulphate and alkali for Toluene and THF
recovery. The Recovered Toluene and THF are recycled. Solvent distillation Residue
Table No 1 :- Input and output and mass Balance for a Batch
Input UOM Qty Output Qty Remark
Ortho Chloro Toluene kg 347 TOTP 166
Tetra Hydro Furan kg 69.50 THF 47 Recovered and recycled
Magnesium kg 59 Toluene 38 Recovered and recycled
Toluene kg 43 THF 5 Process Loss
Phosphorus Tri Chloride kg 114.60 Toluene 3 Process Loss
Water kg 500 Aq.Effluent PH-2 HCOD
742.50 To ETP for Treatment Contains Magnesium Chloride, Sodium Chloride
HCl 30 % kg 66 Solvent Residue 250 To CHWTSDF
Sodium Chloride kg 60.80 Carbon 10.50 To CHWTSDF
NaOH flakes kg 12 Isopropanol 80 Ml for II nd crop
Ferrous Sulphate kg 1.60 Isopropanol 2 Process Evaporation loss
Isopropyl Alcohol kg 70 Drying loss 10 Evaporation loss
Activated Carbon kg 10.50 --------------- ----- ------------------------
Total kg Total 1354 ----------------------
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 71
Rout of Synthesis for Tri O- Phenyl Phosphine
CH3
Teytra Hydro FuranCl
1-chloro-2-methylbenzene
Mol.Wt 126.58
+ Mg.
CH3
MgCl
Grignard Reagent
CH3
MgClToluene/PCl3
Water/HCl
Isopropanol
P
trio-tolylphosphine
Mol.Wt 304.17
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 72
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 73
Table No. 2:- Pollution load. Effluent in m3, Rest all figs are in kg Stage Effluent in lit
Solvent
Residue
Carbon Hyflow Spent
Solvent
Gas
Generated
Inorganic
Salt
Organic
Residue
LCOD HCOD Name Qty
I ----- 742.50 250 12.50 ------- ----- ------ ----- ------- 80
M 8910 -3000 150 ----- ---- ----- ---- ---- 960
D 356.40 120 6.0 ---- ----- ----- ---- ----- 38.40
Organic Residue as Mother Liquor is recycled. M- Pollution load per month, D- Pollution load per day.
1. No gas is produced or generated during the reaction processing.
2. The reaction is not exothermic or run away or pressure.
3. Toxic and hazardous raw material used 1. Toluene 2. Sulphuric acid.
Table No. 3 :- Solvent Balance of Tri-O- phenyl Phosphine.
Sr.No/
Stage
Qty in Kg/Day
Name of
the solvent
Qty
Used
Recovered
[Distilled]
Fugitive
loss
Distillation
Process
loss
To
waste
Water
Distillation
Residue
Product
drying
loss
Spent
Solvent
Fresh
Make
Up
I THF 59 47 --- 5 7 ---- --- -- 17
2 Toluene 43 38 --- 3 2 250 ---- --- 5
3 Isopropanol 70 * ------- ----- 2 ---- ---- ---- --- ------
*-Isopropanol Ml is recycled for recovery of II nd crop.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 74
Table No. 4 :- Matrix showing Molecular weight, Moles, molar ratio and consumption
The below figures of the respective raw material are representative of a batch.
Name of
Key RM
Details Mol.
Wt
Qty kg Moles Molar
Ratio
Existing
Consumption
Proposed
Consumption
Net
Consumption
O Chloro
Toluene
Raw
material
126.58 347 2.741 1 ----------- 347 347
Magnesium Reagent 59 24 2.458 0..89 ---------- 59 59
PCl3 Raw
material
137.34 114.60 0.830 0.30 ---------- 114.60 114.60
NaoH Reagent ----- 12.50 ---- ---- ----- 12.50 12.50
Ferrois
Sulphate
Regent ----- 1.60 ------ --- ---- 1.60 1.60
Isopropanol Solvent ------ 70 ---- --- ------- 70 70
Toluene Solvent ----- 43 ----- ---- ----- 5 5
Note: - Solvents is in terms of volume and not based on mole ratio
Key Raw materials are considered as they are involved to build the desired molecule.
10. Product Name- Cilnidipine Qty/Month 150.00kg.
Batch Output 30 kg
No of Batches/ Month 5
No of working days 25
Brief Manufacturing Process-
2- Methoxyethyl 3-Oxybutanone is condensed with 3-Nitrobenzaldehyde in presence of
ammonium carbonate and methanol as solvent, The reaction mass is refluxed for 2-6 hrs,
till the reaction is complete. The reaction mass is cooled to ambient and further cooled to
0-5 °c and centrifuged, washed with chilled methanol to get stage I as 2-Methoxy 3-amino-
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 75
2-enolate. The product is unloaded and dried in tray dryer to get dry stage I. Output 10.50
kg.
Route of synthesis Cilnidipine Stage I
+ Ammonium carbonate
Mol Wt 96.09
+
METHANOL
O
O
O
O
2-methoxyethyl 3-oxobutanoate
NH2
O
O
O
Mol.Wt 160.17
(Z)-2-methoxyethyl 3-aminobut-2-enoate
Mol.Wt 159.18
+ +2H2O NH3 + CO2
Mol.Wt 18 Mol.Wt 17 Mol.Wt 44
Table No 1:- Input and output and mass balance
Input UOM Qty Output Qty Remark
RM I kg 11.0 Stage I 10.50 Stage I-Product
Methanol kg 150 Water 1.18 Water formed in the Reaction.
Ammonium Carbonate kg 6.30 CO2 2.90 Let to air
Ammonia 1.12 Let to Scrubber
Methanol 120 Rec and Recycled
Methanol 05 Process Loss
Solvent Residue
21.60 Send to CHWTSDF
------------------------- ------
----- Methanol 05 Drying loss
Total kg 167.30 Total 167.30 ------------------
RM I- 2-Mmethoxyethyl -3-oxybutanonoate,
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 76
Table No. 2:-Pollution load. Effluent in m3, Rest all figs in kg.
Stage Effluent in m3
Solvent
Residue
Carbon Hyflow Spent
Solvent
Gas
Generated
Inorganic
Salt
Organic
Residue LCOD HCOD Name Qty
I ------ ------- 21.60 ------ ------- ----- CO2
NH3
2.90
1.12
------- -------
M ------- ------- 944.50 ----- ----- ---- CO2
NH3
14.50
5.66-
---- -------
D -------- ------ 37.78 ----- ---- ----- CO2
NH3
0.58
0.226
----- -----
M- Pollution load per month, D- Pollution load per day.
1. NH3 and CO2 gas is generated during the reaction process. NHE is connected to
scrubber, while CO2 is left to air.
2. The reaction is not exothermic or run away or pressure.
3. Toxic and hazardous raw material used- Nil
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 77
Table No. 3:- Solvent Balance of Stage I of Cilnidipine
Sr.
No/
Stage
Qty in Kg/Day
Name of
the
solvent
Qty
Used
Recovered
[Distilled]
Fugitive
loss
Distillation
Process
loss
To
waste
Water
Distillation
Residue
Product
drying
loss
Spent
Solvent
Fresh
Make
Up
I Methanol 30 24 Nil 1.0 --- Nil Nil Nil 6.0
Brief Manufacturing Process for Cilnidipine Stage II
Cinnamyl -3-oxobutanoate is condensed with 3-Nitro Bnezaldehyde in methanol. After reaction
completion, piperidine and 2-Methoxy ethanol is added and reaction mass is heated to reflux for 4-
5 hrs. The completion of the reaction is monitored on TLC. After completion of the reaction, the
reaction mass is cooled to ambient and water is added.
Acetic acid is added to neutral the reaction mass. The product formed is centrifuged and washed
with water, spin dried and unloaded. The wet product is dried in tray dryer to get dry CILNIDIPINE.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 78
Route of Synthesis for Stage II-
Cilnidipine.
NH2
O
O
O
(Z)-2-methoxyethyl 3-aminobut-2-enoate
Mol.Wt 159.18
O
O O
cinnamyl 3-oxobutanoate
Mol.Wt 218.25
+
NO2
Methanol
CHO
NO2
O O
O
(2E)-cinnamyl 2-(3-nitrobenzylidene)-3-oxobutanoate
Mol.Wt-351.35
1. Piperdinne
2. Water
3.Acetic acid
NH
O2N
O
O
O
O
cinnamyl 5-(1-(2-methoxyethoxy)vinyl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3-carboxylate
Mol Wt 490.21
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 79
Table No. 3:- Batch Input and output and mass balance
nput UOM Qty Output Qty Remark
RM I kg 14 Stage II 30 Final Product
RMII kg 9.69 Water 10 Drying Loss
Methanol kg 100 Spent Solvent
241.20 Sale to Recycler
Piperdine kg 5 ------- ------- ------------------
RMIII kg 10.50 ------------ ------- ------------------
Acetic acid kg 5 ------- -------- ------------------
Water kg 100 ---------- ------- -------
Total kg 224.10 Total 224.10 -------------------
Table No. 4 :-Pollution load of Stage II of Cilnidipine. Effluent in m3, Rest all figs in kg.
Stage Effluent in m3
Solvent
Residue
Carbon Hyflow Spent
Solvent
Gas
Generated
Inorganic
Salt
Organic
Residue
LCOD HCOD Name Qty
I ------ ------- ----- ------ ------- 214.1 ----- ----- ------- -------
M ------- ------- ------ ----- ----- 1070.50 ------ ----- ---- -------
D -------- ------ -------- ----- ---- 42.82 ------- ----- ----- -----
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 80
Table No. 5 :-Solvent Balance of STAGE II of Cilnidipine
Sr.N
o/
Stag
e
Qty in Kg/Day
Name
of the
solven
t
Qty
Use
d
Recover
ed
[Distille
d]
Fugiti
ve
loss
Distillati
on
Process
loss
To
wast
e
Wat
er
Distillati
on
Residue
Produ
ct
dryin
g loss
Spent
Solve
nt
Fres
h
Mak
e Up
I
Methan
ol
20 ---------- Nil ----- ---- Nil Nil Nil 20
No solvent recovery, Mother liquor sale to recycler as spent solvent
Table No. 6 :- Matrix showing Molecular weight, Moles, molar ratio and consumption
The below figures of the respective raw material are representative of a batch.
Name of
Key RM
Deatils Mol.Wt Qty
kg
Moles Molar
Ratio
Existing
Consumption
Proposed
Consumption
Net
Consumption
RM1 Raw
Material
160.17 11 0.0685 1 ------- 11 11
RMII Raw
Material
218.25 14 0.0641 1 ------------ 14 14
RMII Raw
Material
153.12 9.69 0.0632 0.98 ---------- 9.69 9.69
Ammonium
Carbonate
Reagent 96 6.30 0.0656 0.95 --------------- 6.30 6.30
Methanol Solvent ------ 100 ---- --- --------- 100 100
Note: - Solvnets is in terms of volume and not based on mole ratio.
Key Raw materials are considered as they are involved to build the desired molecule
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 81
11. Product Name- Triclabendazole Qty/Month 80.00kg.
Batch Output 16 kg
No of Batches/ Month 5
No of working days 25
Brief Manufacturing Process
3,4-Dichloro Aniline is reacted with Acetic anhydride,the acetylated product is further nitrated in
the presence of Nitric and sulphuric acid to get 3,4-Dichloro-2-Nitro phenyl acetamide. The
reaction is carried out in solvent EDC [ Ethylene di chloride]
Route of Synthesis Triclabendazole Stage-I
NH2Cl
Cl
+ [CH3CO]2 O
3,4-Dichloro Aniline
Mol.Wt---162.02
Acetic anhydride
Mol.Wt--102.
NHCOCH3Cl
Cl
+
N-(3,4-dichlorophenyl)acetamide
Mol.Wt-204
NHCOCH3Cl
Cl
N-(3,4-dichlorophenyl)acetamide
Mol.Wt-204
NHCOCH3Cl
Cl NO2
N-(4,5-dichloro-2-nitrophenyl)acetamide
Mol.Wt-249
HNO3/ H2SO4
EDC/ Water
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 82
Table No. 1:- Input and output and mass Balance Stage I Triclabendazole
Input UOM Qty Output Qty Remark
3,4- Dichloro Aniline kg 10.50 Stage I 14.30 Product for next stage
Acetic anhydride kg 6.50 EDC 96 Rec and used
HNO3 Kg 4.0 EDC 0.80 Distillation loss
Sulphuric acid kg 10 Carbon Di Oxide gas
4.50 Let to air
Ethylene di chloride Kg 100 EDC 5.2 Distillation Residue
Soda Ash kg 10.80 Aq.Effleunt HCOD
421 To ETP for treatment Contains Sodium
Sulphate and acetic acid
Water kg 400 --------- ---- --------
Total kg 541.80 Total 541.80 ------------------
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 83
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 84
Table No. 2:-Pollution load. Effluent in m3, Rest all figs in kg Stage I Triclabendazole.
Stage Effluent in m3
Solvent
Residue
Carbon Hyflow Spent
Solvent
Gas
Generated
Inorganic
Salt
Organic
Residue
LCOD HCOD Name Qty
I ------ 0.421 5.20 ------ ------- ----- CO2 4.5 ------- -------
M --- 2.105 26 ---- ---- --- CO2 22.50 ---- -----
D ----- 0.0842 1.04 ----- ----- ----- CO2 0.90 ------ -----
Table No. 3:- Solvent Balance Stage I Triclabendazole
Sr.No/
Stage
Qty in Kg/Day
Name
of the
solvent
Qty
Used
Recovered
[Distilled]
Fugitive
loss
Distillation
Process
loss
To
waste
Water
Distillation
Residue
Product
drying
loss
Spent
Solvent
Fresh
Make
Up
I EDC 50 46 ---- 0.16 --- 1.04 Nil Nil 4.0
I Water 200 ---- ---- ----- 200 --- --- --- 200
Table No. 4: Matrix showing Molecular weight, Moles, molar ratio and consumption of Stage I
Triclabendazole
The below figures of the respective raw material are representative of a batch.
Name of
Key RM
Details Mol.
Wt
Qty
kg
Moles Molar
Ratio
Existing
Consumption
Proposed
Consumption
Net
Consumption
3,4-
Dichloro
Aniline
Raw
material
162.02 10.3 0.0635 1 ------ 10.30 10.30
Acetic
anhydride
Raw
material
102 6.50 0.0637 1 ------ 6.50 6.50
HNO3 Raw
material
63 4.0 0.0634 0.99 -------- 4 4
H2SO4 Raw
material
98 10 0.102 1.60 80 10 10
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 85
Soda Ash Reagent 106 10.80 0.10 0.99 ----- 10..0 10.80
Water Solvent --- 400 --- --- ---- 400 400
EDC Solvent ------ 100 ----- ------ ------ 100 100
Brief Process Description for stage II Triclabendazole
2, 3-Dichloro phenol is condensed with Stage I, in presence of potassium Carbonate, solvent DMSO
and Toluene. The reaction completion is ensured on TLC, after completion of the reaction, water is
added to the reaction. Sodium hydroxide flakes are added and the reaction mass is heated to 50 0c
and maintain for 2 hrs. After temperature maintaining, the reaction mass is cooled to ambient. The
product is centrifuged and washed with water till neutral PH, spin dried and unloaded. The wet
product is used for next stage as such. The Ml is settled and toluene is separated, distilled to get
Rec.Toluene, The residue left over is unloaded and send to CHWTSDF for disposal, The Aq .Effluent
containing the salts like KCl and NaCl is send to ETP for treatment.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 86
Route of Synthesis
Cl
Cl
NH
NO2
O
N-(4,5-dichloro-2-nitrophenyl)acetamide
+
2,3-dichlorophenol
Mol.Wt 240 Mol.Wt-163
Cl
Cl
OH
Cl NO2
NH
O
O
ClCl
N-(5-(2,3-dichlorophenoxy)-4-chloro-2-nitrophenyl)acetamide
Mol.Wt 375
Cl NO2
NH
O
O
ClCl
NaOH , Toluene, Water
1.DMSO
2.K2CO3
N-(5-(2,3-dichlorophenoxy)-4-chloro-2-nitrophenyl)acetamide
Mol.Wt 375
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 87
Table No 5:- Input and output and mass Balance Stage II Triclabendazole
Input UOM Qty Output Qty Remark
Stage I kg 14.30 Stage II 18 Used for stage III
2,3-Dichloro Phenol kg 9.40 Aq .Effluent
HCOD
845.10 To ETP for treatments contains DMSO, SODIUM Chloride, and unreacted
organics
Sodium Hydroxide kg 4.4 Toluene 144 Rec and used
Toluene kg 150 Toluene 1.20 Distillation Loss
Dimethyl sulphoxide kg 30 Solvent Residue 4.80 TO CHWTSDF disposal
Pottasium Carbonate kg 5 ------ ----- ----------
Water kg 800 ----- ---- ---------
Total kg 1013.10 Total 1013.10 -------------------------
Process Flow Diagram for Stage II- Triclabendazole
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 88
Table No. 6:-Pollution load. Effluent in m3, Rest all figs in kg Stage II Triclabendazole.
Stage Effluent in m3
Solvent Residue
Carbon Hyflow Spent Solvent
Gas Generated
Inorganic Salt
Organic Residue
LCOD HCOD Name Qty
I ------ 0.845.10 4.80 ---- ---- --- --- --- ------- ------- M --- 4.225.50 24 ----- ---- ---- --- --- ---- -----
D ----- 0.169 0.96 ----- ----- ---- ---- --- ------ -----
Table No. 7:- Solvent Balance of Stage II- Triclabendazole
Sr.No/
Stage
Qty in Kg/Day
Name of the solvent
Qty
Used
Recovered
[Distilled]
Fugitive loss
Distillation
Process loss
To waste
Water
Distillation
Residue
Product drying loss
Spent
Solvent
Fresh Make Up
II DMSO 6 ------ ---- ----- --- ---- Nil Nil 6
II Toluene 30 28.80 0.24 --- ---- 0.96 --- -- 1.20
Table No. 8: -Matrix showing Molecular weight, Moles, molar ratio and Consumption Stage II
Triclabendazole.
The below figures of the respective raw material are representative of a batch.
Name of
Key RM
Details Mol.Wt Qty
kg
Moles Molar
Ratio
Existing
Consumption
Proposed
Consumption
Net
Consumption
Stage I Raw
material
249 14.30 0.057 1 -------------- 14.30 14.30
2.3-
Dichloro
Phenol
Raw
material
163 9.40 0.057 1 ---------- 9.40 9.40
DMSO Solvent ----- 30 ---- --- ---- 30 30
K2CO3 reagent 139 5 0.036 0.63 ----------- 5 5
NaOH
flakes
Regent 40 4.40 0.11 1.92 -------- 4.4 4.4
Water Solvent ----- 800 ----- --- ------ 800 800
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 89
Route of Synthesis for Stage III/IV –Triclabendazole
Cl
Cl
O
Cl
NH2
NO2
5-(2,3-dichlorophenoxy)-4-chloro-2-nitrobenzenamine
Mol.Wt-333
Cl
Cl
O
Cl
NH2
NH2
4-(2,3-dichlorophenoxy)-5-chlorobenzene-1,2-diamine
Cl
Cl
O
Cl
N
N
S
H
Methanol/Raney Ni
Cl
Cl
O
Cl
N
N
SH
H
5-(2,3-dichlorophenoxy)-6-chloro-1H-benzo[d]imidazole-2-thiol
Water/ KOH / CS2
5-(2,3-dichlorophenoxy)-6-chloro-2-(methylthio)-1H-benzo[d]imidazole
Mol. Wt--359
DMS/Methanol
Water
Brief Process Description of Stage III/IV-Triclabendazole
Stage II is hydrogenated in presence of methanol and Raney Ni as catalyst at 40-50 °c. After
complete hydrogenation, the reaction mass is filtered and transferred to another reactor. Methanol
is distilled to half of the volume and cooled to ambient. Potassium Hydroxide flakes is added,
followed by slow addition of carbon di sulphide at ambient temperature. After complete addition of
CS2, the reaction mass temperature is raised to 50 °c and maintained for 3-4 hrs till completion of
the reaction, monitored on TLC. If the reaction is complete .methanol is distilled and water is added
to the reaction mass, stirred for ½ hr and centrifuged to get stage III. The wet material is charged to
another reactor in methanol and dimethyl sulphate is added at ambient .The reaction mass is
stirred for 2 hrs till reaction completion and centrifuged, washed with methanol, spin dried and
unloaded. The wet Triclabendazole is dried in tray dryer to get dry Triclabendazole.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 90
Table No. 9:- Input and output and mass Balance of Stage- III Triclabendazole
Input UOM Qty Output Qty Remark Stage II Kg 17.60 Stage III 18 Used for next stage
Methanol Kg 54 Raney Ni 2 Recovered and recycle
Raney Ni 50% wet Kg 2 Methanol 25 Recovered and recycle
Carbon di sulphide Kg 4.0 Aq.Effluent HCOD
447.60 To ETP for treatment
Potassium Hydroxide Kg 5.0 Hydrogen* 2M3 Excess released to air through water.
Water kg 400 -------- ---- ----------
Hydrogen Gas M3 21
Total kg 482.60 Total 482.60 -------------------
*- Hydrogen gas is not included in mass balance.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 91
Table No. 10:- Pollution load Stage- III Triclabendazole. Effluent in m3, Rest all figs in kg
Stage Effluent in m3
Solvent
Residue
Carbon Hyflow Spent
Solvent
Gas Generated
Inorganic
Salt
Organic
Residue
LCOD HCOD Name Qty
III ------ -
0.4476
------ ---- ----- ----- H2 2m3 ------- -------
M ------- -2,238 ------- ---- ---- ----- H2 10 m3 ---- -------
D -------- 0.088 ----- ---- ---- ------ H2 0.4m3 ----- -----
M- Pollution load per month, D- Pollution load per day.
Table No.11:- Solvent Balance of Stage- III Triclabendazole
Sr.No/
Stage
Qty in Kg/Day
Name of
the
solvent
Qty
Used
Recovered
[Distilled]
Fugitive
loss
Distillation
Process
loss
To
waste
Water
Distillation
Residue
Product
drying
loss
Spent
Solvent
Fresh
Make
Up
I Methanol 10.80 5.0 Nil --------- ----- Nil Nil Nil 8.64
Table No. 12 :- Matrix showing Molecular weight, Moles, molar ratio and Consumption of
Stage- III Triclabendazole
The below figures of the respective raw material are representative of a batch.
Name of
Key RM
Details Mol.Wt Qty
kg
Moles Molar
Ratio
Existing
Consumption
Proposed
Consumption
Net
Consumption
Stage II Raw material
332 17.60 0.0530 1 --------- 17.60 17.60
Methanol Solvent ----- 54 ---- ---- --- 29 29
Raney No Catalyst --- 2 ---- ---- --- 00 00
Water Solvent --- 400 --- --- --- 400 400
KOH Reagent 56 4 0.071 1.30 ------- 4 4
CS2 Reactant 76 5 0.065 1.03 ------- 5 5
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 92
Note:- Solvent is in terms of volume and not based on mole ratio.
Key Raw materials are considered as they are involved to build the desired molecule.
Brief Process Description for Stage IV Triclabendazole:-
Triclabendazole stage III is charged in methanol and cooled to ambient. To the reaction mass is
added dimethyl sulphate at ambient. The reaction mass is stirred till reaction is complete.
Completion of reaction mass is ensured on TLC. Water is added after completion of the reaction and
pH of the reaction mass is adjusted with liquor ammonia. The reaction mass is centrifuged and
washed with water till pH-7, spin dried and unloaded. The wet Triclabendazole is dried in Tray
dryer to get dry Triclabendazole.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 93
Table No. 13:- Batch Input and output and mass Balance of Stage IV Triclabendazole
Input UOM Qty Output Qty Remark
Stage III kg 16.90 Product stage IV
16.70 Triclabendazole
Methanol kg 54 Water 15 Drying Evaporation loss
Dimethyl Sulphate kg 6.20 Aq.Effluent 550.40 To ETP for treatment
Water kg 500
Aq.Ammonia kg 5
Total kg 582.10 Total 582.10 -------------------
Table No. 14:-Pollution load of Stage IV Triclabendazole. Effluent in m3, Rest all figs in kg.
Stage Effluent in m3
Solvent
Residue
Carbon Hyflow Spent
Solvent
Gas
Generated
Inorganic
Salt
Organic
Residue LCOD HCOD Name Qty
I ------ 0.550 ----- ------ ------- ----- ----- ------- -------
M ------- 2.750 ------ ----- ----- ------ ----- ---- -------
D -------- 0.11 -------- ----- ---- ------- ----- ----- -----
Table No. 15:- Solvent Balance of Stage IV Triclabendazole
Sr.No/
Stage
Qty in Kg/Day
Name of
the
solvent
Qty
Used
Recovered
[Distilled]
Fugitive
loss
Distillation
Process
loss
To
waste
Water
Distillation
Residue
Product
drying
loss
Spent
Solvent
Fresh
Make
Up
I Methanol 10.80 ---------- Nil ----- ---- Nil Nil Nil 10.80
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 94
Table No. 16 :- Matrix showing Molecular weight, Moles, molar ratio and Consumption of
Stage IV Triclabendazole,
The below figures of the respective raw material are representative of a batch.
Name of
Key RM
Details Mol.W
t
Qty
kg
Mole
s
Mola
r
Ratio
Existing
Consumptio
n
Proposed
Consumptio
n
Net
Consumptio
n
Stage III Reactan
t
345 16.9
0
0.048 1.0 ------- 16.90 16.90
Methanol Solvent ---- 54 ---- ---
DImethyl
Sulphate
Reactan
t
110 6.20 0.056 1.17 ------- 6.20 6.20
Aq.Ammoni
a
Reagent ------ 5.0 -----
Water Solvent ------- 500 --- --- --- 500 500
Note: - Solvent is in terms of volume and not based on mole ratio.
Key Raw materials are considered as they are involved to build the desired molecule.
TRICLABENDAZOLE CUMULATIVE POLLUTION LOAD
Table No. 17:- Cumulative Pollution load of Stage IV Triclabendazole.
Effluent in m3, Rest all figs in kg. / Day
Stage Effluent in m3
Solvent
Residue
Carbon Hyflow Spent
Solvent
Gas Generated
Inorganic
Salt
Organic
Residue LCOD HCOD Name Qty
I ------ 0.0842 1.04 ----- ----- ---- ---- --- --- ---
II ------- 0.169 ---- ------ ----- ---- CO2 0.90 ----- ----
III -------- 0.088 ---- ----- ---- ---- H2 0.40 m3 --- --
IV ----- 0.11 --- --- --- -- -- -- -- --
Total 0.452 1.04 --- --- --- CO2
H2
0.90
0.4 m3
------ ------
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 95
12. Name of the Product –-Voglibose Qty/Month 25.00kg.
Batch Output 5 kg
No of Batches/ Month 5
No of working days 25
Brief Manufacturing Process for- Voglibose Charge water and Dimethyl Sulphoxide in a clean Reactor. Charge crude Voglibose under stirring.
Heat the reaction mass to reflux and maintain for 4 hrs. After reflux is over cool the reaction mass to
10 °c and maintain for 1 hr. Centrifuge the reaction mass and spin dry. Unload the wet material and
dry in a vacuum tray dryer to get dry Voglibose.
Route of Synthesis- HO
HO
HO OHOH
NH
OH
OH
5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol
Mol Wt---267.28
HO
HO
HO OHOH
NH
OH
OH
5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol
Mol Wt---267.28
1. Water2.DMSO3.Carbon
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 96
Table No. 1 :- Input and output and mass Balance for a Batch
Input UOM Qty Output Qty Remark
Crude Voglibose kg 5.5 Pure Voglibose 5.00 Final Product
Water kg 5 Carbon 1.0 TO CHWTSDF
Dimethyl Sulphoxide kg 5 Aq. Effluent HCOD
9.50 To ETP for Treatment
Activated Carbon kg 1 Drying Loss 01 -
Total kg 16.50 Total 16.50 ------------------
Process Flow diagram-
Table No. 1:-Pollution load. Effluent in m3, Rest all figs in kg.
Stage Effluent in m3 Solvent
Residue
Carbon Hyflow Spent
Solvent
Gas Generated
Inorganic
Salt
Organic
Residue LCOD HCOD Name Qty
I ------ 9.50 ----- 01 ----- ------ ------- ------- ------- -------
M ------- -47.50 -------- 05 ----- ------- -------- ------ ---- -------
D -------- 1.90 ----- 0.20 ---- ---- ------- ------- ----- -----
M- Pollution load per month, D- Pollution load per day.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 97
1. NH3 and CO2 gas is generated during the reaction process. NHE is connected to scrubber,
while CO2 is let to air.
2. The reaction is not exothermic or run away or pressure.
3. Toxic and hazardous raw material used Nil
Table No.2 :- Solvent Balance of Voglibose
Sr.No/
Stage
Qty in Kg/Day
Name of
the
solvent
Qty
Used
Recovered
[Distilled]
Fugitive
loss
Distillation
Process
loss
To
waste
Water
Distillation
Residue
Product
drying
loss
Spent
Solvent
Fresh
Make
Up
I Dimethyl
Sulphoxide
0.20 ------- Nil ------- 0.2 Nil Nil Nil 0.20
Table No 3:- Matrix showing Molecular weight, Moles, molar ratio and consumption
The below figures of the respective raw material are representative of a batch.
Name of
Key RM
Details Mol.Wt Qty
kg
Moles Molar
Ratio
Existing
Consumption
Proposed
Consumption
Net
Consumption
Crude
Voglibose
Raw
material
267.28 5 0.018 1 -------- 5 5
DMSO Solvent ----- -------- ------ ----- --------- 5 5
Water solvent ------ 5 --- ---- ----- 5 5
Note: - Solvents is in terms of volume and not based on mole ratio.
Key Raw materials are considered as they are involved to build the desired molecule.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 98
13. Product Name-Darunavir Qty/Month 100.00kg.
Batch Output 50 kg
No of Batches/ Month 2
No of working days 25
Brief Manufacturing Process-
RMI 4-Amino-N-[2R,3S] [ 3-Amino-2-hydroxyphenyl butyl] isobutyl bezenesulphonamide is
condensed in presence of methylene di chloride as solvent and 2-methyl—2-butanol with
hexahydro furan-3-ol and Disucinimidyl Carbonate. Sulphuric acid is added as a catalyst. The
reaction mass is refluxed for 10-12 hrs. Reaction completion is ensured on TLC. If the reaction is
complete, the reaction mass is cooled to ambient and water is added. The reaction mass is stirred
and settled. The aq Layer is separated and send to ETP for treatment. The organic layer having the
product is washed with water and then distilled off completely under vacuum. To the dry mass is
added cyclohexane and stirred for 10-15 minutes. Cyclohexane organic is washed with alkali
solution .The aq layer is separated and sodium sulphate is added.The reaction mass is stirred and
filtered. Activated carbon is added and the reaction mass is heated to 40-50 °c and filtered. The
clear filtrate is transferred to a clean and dry Reactor. Cyclohexane is distilled 50 % and cooled to
ambient. The product Darunavir is centrifuged and spin dried under Nitrogen blanket. The wet
product is unloaded and dried in vacuum tray dryer to get dry Darunavir. Mother liquor is distilled
off completely and residue is cooled and unloaded and send to CHWTSDF for disposal.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 99
Route of Synthesis-
OH
N
S
CH3
CH3
O
O
NH2
H2N
4-Amino-N-(2R,3S,(3-AMINO-2-HYDROXY-PHENYL BUTYL)-N-ISOBUTYL BENZENESULPHONAMIDE
Mol.Wt-391
+O
O
OH
tetrahydro-2H-furo[2,3-b]furan-3-ol
Mol.Wt-130
1.Disucinimidyl Carbonate
2. Methylene di chloride
3.. Cyclohexane
4. Sodium sulphate
OH
NS
CH3
CH3
O
O
NH2
NH
O
OO
O
DARUNAVIR MOL.WT- 547
Table No.1 :- Input and output and mass Balance of Darunavir
Input UOM Qty Output Qty Remark
RM I kg 45 Darunavir 50.5 Final Product
RMII kg 15 Aq.Effluent 250 To ETP for treatment
DIsucinimidyl Carbonate kg 29 Methylene di chloride 140 Rec and recyceld
Sulphuric acid kg 1.80 Methylene di chloride 4 Distillation loss
2-Methyl-2-butanol kg 1 Cyclohexne 85 Rec and used
Methyleen di chloride kg 150 2-Methyl-2-butanol 1 To effluent
Cyclohexane kg 100 Sodium Sulphate 1.7 To ETP for treatment
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 100
Sodium Hydroxide kg 1.9 Sodium Hydroxide 1.90 To Effluent
Sodium sulphate Kg. 1.70 Cyclohexane 2 Distillation and Process loss
Water kg 250 Activated Carbon 2 TO CHWTSDF
Activated carbon kg 2 Solvent distillation Residue
54.30 TO CHWTSDF
----------------------- kg ----- Drying loss 05 Evaporation loss
Total kg 597.40 Total 597.40
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 101
Table No. 2:-Pollution load of Darunavir. Effluent in m3, Rest all figs in kg.
Stage Effluent in m3
Solvent
Residue
Carbon Hyflow Spent
Solvent
Gas
Generated
Inorganic
Salt
Organic
Residue LCOD HCOD Name Qty
I ------ 250 54.30 2 ----- ------ ---- ---- ------- -------
M ------- 500 108 4 ----- ------- ----- ----- ---- -------
D -------- 0.020 4.344 0.16 ----- ------- ------- ------- ----- -----
M- Pollution load per month D- Pollution load per day.
Table No. 3:- Solvent Balance of Darunavir
Sr.No/
Stage
Qty in Kg/Day
Name of
the solvent
Qty
Used
Recovered
[Distilled]
Fugitive
loss
Distillation
Process
loss
To
waste
Water
Distillation
Residue
Product
drying
loss
Spent
Solvent
Fresh
Make
Up
I MDCl 24 22.40 Nil 0.64 0.01 8.688 Nil Nil 1.60
I Cyclohexane 16 14.40 Nil 1.50
Table No. 4:- Matrix showing Molecular weight, Moles, molar ratio and consumption
The below figures of the respective raw material are representative of a batch.
Name of Key RM
Details Mol.Wt Qty kg
Moles Molar Ratio
Existing Consumption
Proposed Consumption
Net Consumption
RMI Reactant 391 45 0.115 1 ----------- 45 45
RMII Reactant 130 15 0.115 1 ---------- 15 15
Disu.Carbonate Catalyst 256 29 .113 0.985 -------- 29 29
Sulphuric acid Catalyst 98 1.8 ----- ---- -------- 1.8 1.8
2-Methyl-2-
Butanol
Reagent 1 ----- ---- ------- 1 1
MDC Solvent --------- 150 ----- ---- ---- 10 10
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 102
Sodium
Sulphate
Reagent ------- 1.90 ---- ---- --- 1.90 1.90
Cyclohexane Solvent ------ 100 --- -- ------- 15 15
Water solvent ------ 500 --- --- -------- 500 500
Carbon Adsorbent --- 2 ---- --- --- 2 2
Note: - Solvents is in terms of volume and not based on mole ratio.
Key Raw materials are considered as they are involved to build the desired molecule.
14. Product Name- MONTELUKAST SODIUM Qty/Month 750.00kg.
Batch Output 75.00 kg
No of Batches/ Month 10
No of working days 25
Brief Manufacturing Process-
Intermediate I is condensed with 2-[Sulfonyl]-Ethyl Cyclopropyl acetic acid in presence of
Acetonitrile and Toluene as solvent. Di isopropyl amine is used as a catalyst. The
Montelukast base is converted to sodium salt in presence of NaoH and Methanol. The
product Montelukast sodium is centrifuged and washed with chilled methanol, spin dried
and unloaded. The wet product is dried in vacuum tray dryer.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 103
Route of Synthesis-
HO
Cl
2-(2-(3-(3-((E)-2-(2-chloronaphthalen-7-yl)vinyl)phenyl)propyl)phenyl)propan-2-ol
OH
Mol.Wt 457
+
HO
COOH
2-(1-(hydroxymethyl)cyclopropyl)acetic acid
Mol.Wt 130
1. Tolueen, Acetonitrile
2.DiIsopropyl amine
3. NaOH , HCl , NaCl
4.Methanol5.Carbon , Water
HO
Cl
O
+
COONa
sodium 2-(1-((1-(3-((E)-2-(2-chloronaphthalen-7-yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2-yl)phenyl)propoxy)methyl)cyclopropyl)acetate
Mol.Wt---591
Table No. 1:- Batch Input and output and mass Balance
Input UOM Qty Output Qty Remark
RMI-hydroxy propyl-phenyl-2-Propanol
kg 99.40 Montelukast Sodium 75 Product
Sulphonyl methyl Cyclopropane acetic acid [
RMII ]
kg 31.71 Aq.Layer as Effluent HCOD , contains NaCl
250 To ETP for treatment.
Methano sulphonyl Chloride kg 24.87 Water formed during reaction
2.22 To waste Water
Sodium Hydroxide kg 13.62 Toluene 68.25 Rec. and used
N,N-Di isopropyl Ethyl amine
kg 0.50 Toluene Distillation loss 0.38 Distillation and Process loss
HCl 30% Kg 3.42 Toluene 0.26 To Waste Water
Sodium Chloride Kg 0.50 Toluene solvent Residue 35.00 To CHWTSDF
Acetic acid kg 1 Acetonitrile 45.00 Rec and used Toluene kg 75 Acetonitrile 0.33 Recovery process loss
Aceto Nitrile kg 65 Aceto nitrile 42.50 Solvent Residue
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 104
Methanol kg 100 Hexane
95.00
Rec and used
n-Hexane kg 130 Hexane 2.50 Distillation loss
Water kg 115 Hexane 15.0 Solvent Residue
Activated Carbon kg 01 Activated Carbon 1 To CHWTSDF as HW ----------------------------- kg ---- Sodium Chloride 13.20 To waste Water
------------------- kg ---- Drying Loss 15.38 Hexane Drying Loss
Total kg 661.02 Total 661.02 -----------
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 105
Table No. 2:-Pollution load of Montelukast Sodium.
Effluent in m3, Rest all figs in kg.
Stage Effluent in m3
Solvent
Residue
Carbon Hyflow Spent
Solvent
Gas
Generated
Inorganic
Salt
Organic
Residue LCOD HCOD Name Qty
I ------ 0.250 92 1 ----- ---- ---- --- ------- -------
M ------- 2.500 920 10 ----- ----- ------- ---- ---- -------
D -------- 0.10 40.50 0.40 ----- ----- ----- --- ----- -----
M- Pollution load per month D- Pollution load per day.
Table No.3 :- Solvent Balance of Montelukast Sodium
Sr.No/ Stage
Qty in Kg/Day Name of
the solvent
Qty Used
Recovered [Distilled]
Fugitive loss
Distillation Process
loss
To waste Water
Distillation Residue
Product drying
loss
Spent Solvent
Fresh Make
Up
I Methanol 10 ---- ---- ----- 10 Nil Nil Nil 10
I Toluene 30 27 ------- 0.38 0.26 14 --- --- 3.0
I Hexane 52 37.96 ----- 1.0 --- 6.0 6.152 --- 14.40
Table No. 4:- Matrix showing Molecular weight, Moles, molar ratio and consumption of
Montelukast Sodium
The below figures of the respective raw material are representative of a batch.
Name
of
Key RM
Details Mol.Wt Qty
kg
Moles Molar
Ratio
Existing
Consumption
Proposed
Consumption
Net
Consumption
RMI Reactant 458 99.40 0.21 1 --------- 99.40 99.40
RMII Reactant 146 31.71 0.71 3.30 -------- 31.71 31.71
Note: - Solvents is in terms of volume and not based on mole ratio.
Key Raw materials are considered as they are involved to build the desired molecule.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 106
15. Product Name- Losartan Base
Brief Process Description -
Losartan intermediate is reacted with sodium azide in presence of Triethyl amine and Toluene as
solvent. The reaction temperature is 90-95°C and maintained for 30 hrs. The reaction completion is
ensured on TLC. If TLC is clear the reaction mass is cooled to ambient and quenched in sodium
hydroxide solution at 25-30 °c. After complete quenching the reaction mass is stirred for 10-15
minutes and settled for 20-30 minutes. The organic layer is separated and distilled to get recovered
Toluene, which is recycled. The aq layer having product is transferred to another clean Reactor and
added carbon and hyflow to it. The reaction mass is heated to 60-65 °c and maintained for 20-30
minutes. The hot reaction mass is filtered and clear filtrate is transferred to clean Reactor. The
reaction mass is cooled to ambient an d solution of sodium nitrite is added slowly at 25-30 °c, After
addition of sodium nitrite, pH of the reaction mass is adjusted to 2-3 with HCL/WATER mixture.
Sodium hydrosulphite is added, the reaction mass is stirred and PH is rechecked. The product
formed is centrifuged and washed with water to a neutral pH. The wet cake is slurried in DM water,
stirred and centrifuged. The wet cake is recharged in a Reactor having IPA, stirred and centrifuged.
The wet product is dried in Tray Dryer to get Dry Losartan K; ML is distilled to get rec.IPA. The
solvent Residue is cooled and unloaded and send to CHWTSF for disposal.
Qty/Month 975.00kg.
Batch Output 195 kg
No of Batches/ Month 5
No of working days 25
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 107
Route of Synthesis-
CN
N
N
HO
Cl
1. Toluene
2.TEA.HCl
1. NaOH
2. Sodium NitriteN
N
HO
Cl
HN
N N
N
LOSARTAN BASE MOL.WT 422.91LOSARTN INTERMEDIATE MOL.WT 379
( 4-(2-Butyl-4-Chloro-5-hydroxy menthyl)-1
H- Imidazole-1-Yl] Biphenyl -2-Carbonate
(2-Butyl-4-chloro-1-[(2<(1H-Tetrazole-5-yl)[1,2< Biphenyl]-4ylmenthyl]-1H-Imidazole-5-methanol
SYNTHETICROUTE FOR LOSARTAN BASE
Table No.1 :- Batch Input and output and mass Balance of Losartan Base
Input UOM Qty Output Qty Remark
Losartan Intermediate kg 200 Product 195 Losartan potassium
Toluene kg 344 Aq. Effluent 1900 To ETP for treatment
Sodium Azide kg 136 Toluene 340 Rec and reused
Triethyl amine kg 288 Toluene 02.0 Distillation loss
NaOH solution [ 120+ 600 watrr]
kg 720 Toluene 54 Distillation Residue
Sodium Nitrite kg 60 Toluene 02 To waste Water
Carbon kg 5 IPA 165 Rec and used
Hyflow kg 2 IPA 05 Distillation loss
Sodium hydro Sulphite kg 5 IPA 20 Solvent Residue
Water/ HCl mixture kg 400 IPA 20 Drying Loss
Water for washing and slurry
kg 350 Carbon- 5 To CHWTSDF
Isopropanol kg 200 Hyflow 2 To CHWTSDF
Total kg 2710 Total 2710 -------------------
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 108
Table No. 2:-Pollution load of Losartan Base.
Effluent in m3, Rest all figs in kg.
Stage Effluent in m3
Solvent
Residue
Carbon Hyflow Spent
Solvent
Gas
Generated
Inorganic
Salt
Organic
Residue LCOD HCOD Name Qty
I ------ 1.900 74 5 2 ----- ---- --- ------- -------
M ------- 9.500 370 25 10 ----- ------ ---- -------
D -------- 0.236 14.80 1 0.40 ------ ------ --- ----- -----
M- Pollution load per month, D- Pollution load per day.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 109
Table No.3 :- Solvent Balance of Losartan Base
Sr.No/
Stage
Qty in Kg/Day
Name
of the
solvent
Qty
Used
Recovered
[Distilled]
Fugitive
loss
Distillation
Process
loss
To
waste
Water
Distillation
Residue
Product
drying
loss
Spent
Solvent
Fresh
Make
Up
I Toluene 68.80 67.90 Nil 0.40 0.40 54 Nil Nil 0.80
I IPA 40 33 Nil 1 --- 20 4.0 ---- 7.0
Table No.4: - Matrix showing Molecular weight, Moles, molar ratio and consumption of Losartan
Base
The below figures of the respective raw material are representative of a batch.
Name of
Key RM
Details Mol.Wt Qty
kg
Moles Molar
Ratio
Existing
Consumption
Proposed
Consumption
Net
Consumption
Intermediate
I
Reactant 379 200 0.52 1 --------- 200 200
Sodium
azide
Reactant 65 136 0.47 0.92 -------- 136 136
TEA.HCl Catalyst 102 288 2.80 5.40 -------- 288 288
Sodium
Nitrite
Reactant 69 60 0.86 1.67 -------- 60 60
Water Solvent ---- 1550 ---- ---- ---- 1550 1550
Toluene Solvent ---- 344 -- -- ---- 4 4
IPA Solvent --- 200 --- --- -- 35 35
Note: - Solvents is in terms of volume and not based on mole ratio.
Key Raw materials are considered as they are involved to build the desired molecule.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 110
16. Product name- Sparfloxacin Qty/Month 50.00kg.
Batch Output 16.70 kg
No of Batches/ Month 3
No of working days 25
Brief Process Description-
Ethyl 1-Cyclopropyl -5, 6, 7, 8-tetra fluoro-4-0xo-1, 4-dihydro quinoline carboxylate is condensed
with Benzyl amine in presence of sodium Carbonate and toluene. The reaction is carried out at
reflux temperature. Reaction completion is ensured on TLC, after completion of the reaction, the
reaction mass is cooled and water is added. Toluene layer is separated and distilled to get
rec.Toluene which is recysled. Solvent distillation residue is unloaded and sends to CHWTSDF for
disposal. To the aq layer HCL is added, heated to reflux, maintained for 2 hr, cooled and the product
as stage I, is centrifuged and used for next stage as wet. Stage I, is charged in methanol. 2,6 –
Dimethyl piperzine is added along with N-Methyl pyrrolidine, The Reaction mass is refluxed and
maintained for 10-12 hrs. The reaction completion is ensured on TLC. After completion of reaction,
methanol and N-methyl pyrrolidine is recovered by distillation and water is added to the reaction
mass, PH of the reaction mass is adjusted to 8-9 with sodium hydroxide and reaction mass is
filtered. The filtrate is acidified with acetic acid to precipitate Sparfloxacin. The product is isolated
by centrifuging and washed with water. Wet product is unloaded and dried in Tray dryer to get dry
Sparfloxacin.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 111
Route of Synthesis of – Sparfloxacin—Stage I
N
F
F
F
F
O
COOC2H5
ethyl 1-cyclopropyl-5,6,7,8-tetrafluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate
Mol.Wt---329
NH2
phenylmethanamine
Mol.Wtn 107.15
+
N
F
F
NH
F
O
COOC2H5
ethyl 5-(benzylamino)-1-cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate
Mol.Wt-416.39
+ HF
Mol.Wt-20
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 112
N
F
F
NH
F
O
COOC2H5
ethyl 5-(benzylamino)-1-cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate
Mol.Wt-416.39
HCL
Toluene
N
F
F
NH2
F
O
COOH
+ C2H5OH
+
OH
Benzyl Alcohol
Ethyl Alcohol
Mol.Wt- 108.145-amino-1-cyclopropyl-6,7,8-trifluoro-
1,4-dihydro-4-oxoquinoline-3-carboxylic acid
Mol.Wt-298.22
Table No. 1:- Batch Input and Output and Mass Balance Stage I of Sparfloxacin
Input UOM Qty Output Qty Remark
Ethyl cyclopropyl tetra fluoro-4-oxo di hydro
quinoline--- RMI
kg 18.50 Stage I 13.40 Used for next stage
Benzyl amine kg 6 Toluene 55 Rec and recycled
Hydrochloric acid kg 2 Toluene 02 Distillation loss
Toluene kg 60 Toluene 11.90 Solvent residue
Sodium carbonate kg 1.20 Toluene 0.50 To waste Water
Water kg 30 Aq.Effluent 30 To ETP for treatment
------------------- kg ----- Sodium Chloride 1.70 To waste water to ETP
------------------------- kg -------- Carbon Di Oxide 0.50 Let to air
------------------------- kg ------ HF acid 0.9 To waste water
-------------------------- kg ---- Ethanol 2.10 To waste Water
------------------- kg ---- ------- ------ -----------------
--------------------------- kg --- ------------ ----- ----------
Total kg 118 Total 118 -------------------
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 113
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 114
Table No. 2:-Pollution load of Sparfloxacin Stage I.
Effluent in m3, Rest all figs in kg.
Stage Effluent in m3
Solvent
Residue
Carbon Hyflow Spent
Solvent
Gas
Generated
Inorganic
Salt
Organic
Residue LCOD HCOD Name Qty
I ------ 0.367 11.90 ----- ---- ----- ---- --- ------- -------
M ------- 0.110 35.70 ----- ---- ----- ------ ---- -------
D -------- 0.176 1.428 ----- ----- ------ ------ --- ----- -----
M- Pollution load per month, D- Pollution load per day.
Table No. 3:- Solvent Balance of Sparfloxacin Stage I
Sr.No/
Stage
Qty in Kg/Day
Name of
the
solvent
Qty
Used
Recovered
[Distilled]
Fugitive
loss
Distillation
Process
loss
To
waste
Water
Distillation
Residue
Product
drying
loss
Spent
Solvent
Fresh
Make
Up
I Toluene 7.2 6.59 --- 0.024 0.06 11.90 ---- --- 0.61
I Water 3.6 ----- ----- ----- 3.6 ---- --- --- 3.6
Table No. 4 :- Batch Input and output and mass Balance Sparfloxacin Stage II
Input UOM Qty Output Qty Remark
Sparfloxacin stage I kg 13.40 Sparfloxacin 16.70 Final Product
2,6-d-Methyl Piperzine kg 5.10 Aq Water as effluent
30.00 To ETP for treatment
N-Methyl Pyrrolidine kg 40 .Methanol 32 Rec and used
Methanol kg 40 Methanol 3.5 Distillation loss
Acetic acid kg 1.50 NMP 30 Rec and recycled
Sodium Hydroxide kg 1 NMP 10 To waste water
Water kg 30 Unreacted Stage I 0.730 To waste Water
------------------------- kg ---- Acetic acid 1.50 To waste water
------------------------------ kg ---- NaOH 1 To waste water
------------ ------------ kg ----- Methanol 4.5 To waste water.
------------------------ kg ----- HF 0.70 To waste water
----------------------------- kg ----- Drying Loss 0.37 Product drying loss
Total kg 131 Total 131 -----------
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 115
Route of Synthesis of Sparfloxacin Stage II
N
O
F
F
NH2
COOH
F
5-amino-1-cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid
Mol.Wt-298.06
+
NH
HN
(2R,6S)-2,6-dimethylpiperazine
Mol.Wt 114.19
1. Methanol
2.N-Methyl Pyrrolidine
N
O
F
N
NH2
COOH
FHN
5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-((3R,5S)-3,5-dimethylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid
mol.Wt-392.04
+ HF
Hydrofluoric acid
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 116
Table No. 1:- Pollution load of Sparfloxacin Stage II.
Effluent in m3, Rest all figs in kg.
Stage Effluent in m3 Solvent
Residue
Carbon Hyflow Spent
Solvent
Gas Generated Inorganic
Salt
Organic
Residue LCOD HCOD Name Qty
II ------ 0.384 ----- ----- ---- ----- ---- --- ------- -------
M --- 1.152 --- --- ----- --- --- --- --- ---
D --- 0.0468 --- ---- --- --- --- --- --- --
Table No. 2:- Solvent Balance of Sparfloxacin Stage II
Sr.No/
Stage
Qty in Kg/Day
Name of
the
solvent
Qty
Used
Recovered
[Distilled]
Fugitive
loss
Distillation
Process
loss
To
waste
Water
Distillation
Residue
Product
drying
loss
Spent
Solvent
Fresh
Make
Up
II Methanol 4.80 3.84 --- 0.42 0.54 ---- --- 1.04
II Water 3.60 ---- ---- --- --- 3.56 0.044 --- 3.60
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 117
Table No.3 :- Cumulative Pollution load of Sparfloxacin Stage II.
Effluent in m3, Rest all figs in kg/Day
Stage Effluent in m3
Solvent
Residue
Carbon Hyflow Spent
Solvent
Gas
Generated
Inorganic
Salt
Organic
Residue LCOD HCOD Name Qty
II ------ 0.2248 1.428 ----- ---- ----- ---- --- ------- -------
Table No. -4: - Matrix showing Molecular weight, Moles, Molar Ratio and Consumption.
The below figures of the respective raw material are representative of a batch.
Name of
Key RM
Details Mol..Wt Qty
kg
Moles Molar
Ratio
Existing
Consumption
Proposed
Consumption
Net
Consumption
Tetra
fluoro
Quinoline
Reactant 329 18.50 0.056 1 ------ 18.50 18.50
Benzyl
amine
Reactant 107 6.0 0.056 1 ------- 6 6
Sodium
Carbonate
Reagent 1.2 106 0.011 0.202 -------- 1.2 1.2
Toluene Solvent ----- --60 ---- --- ------ 2.2 2.2
Stage I Rectant 298 13.4 0.044 1 ----- 13.40 13.40
NMP solvetn ---- 40 --- -- --- 10 10
Piperzine Recatnt 114.19 5.10 0.044 1 -------- 5.1 5.1
Methanol Solvent ----- 40 ---- --- ---- 8 8
Water Solvent ----- 30 ---- --- ---- 30 30
Note: - Solvents is in terms of volume and not based on mole ratio.
Key Raw materials are considered as they are involved to build the desired molecule.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 118
17. Product Name- Salbutamol Sulphate
Qty/Month 2.00 MT.
Batch Output 50 kg
No of Batches/ Month 40
No of working days 25
Brief Process Description-
Benzyl Salbutamol is charged in methanol. Nitrogen is flushed and Raney Ni catalyst is charged
under Nitrogen blanket. After charging Raney Ni Catalyst, Hydrogen gas is purged and then a
pressure of 3.5 kg is maintained till reaction is complete. Reaction completion is monitored on TLC.
After completion of the reaction, hydrogen gas is released with nitrogen blanket through water.
After releasing the hydrogen gas, the reaction mass is filtered through hyflow bed and the clear
filtrate is transferred to Clean Reactor
The Raney Ni and Hyflow are removed from the filter under nitrogen and send for recovery. The
clear filtrate cooled to 0-5 °c, AR grade sulphuric acid is added and the reaction mass is stirred for
10-12 hrs. The reaction mass as Salbutamol sulphate is centrifuged and spin dried and charged in
tray dryer to get dry Salbutamol sulphate.
Route of Synthesis-
O
HO NH
OH
2-(tert-butylamino)-1-(4-(benzyloxy)-3-(hydroxymethyl)phenyl)ethanol
Mol.Wt 329.
1.Methanol
2. Raney Ni
3.H2SO4
OH
HO NH
OH
.. SO4
Salbutamol Sulpahte
Mol.Wt 337.30
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 119
Table No. 1:- Batch Input and output and mass Balance of Salbutamol Sulphate
Input UOM Qty Output Qty Remark
Benzyl Salbutamol kg 66.70 Salbutamol sulphate
50 Final product
Methanol kg 416 Raney Ni 10 For recovery
Raney Ni 50 % wet kg 10 Hyflow 4 To HW for disposal
Hydrogen M3 30 Hydrogen 25 M3 Used for Reaction
Nitrogen M3 7 Hydrogen 5 M3 Released to air through water
Hyflow kg 4 Nitrogen 7.0M3 Used for Blanketing
Sulphuric acid 98 % kg 10 Toluene 18.65 Formed during the reaction in spent solvent
Methanol 300 Rec and used
Methanol 102.05 Spent for sale
Methanol loss 07..0 Distillation loss
Drying Loss 15 Product drying
Total kg 506.70 Total 506.70 ------------------
1. The reaction is pressure reaction. Hydrogen gas is used as a reactant. Excess gas is
released through water.
2. No gas is generated during the course of Reaction.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 120
Table No.2 :-Pollution load of Salbutamol Sulphate. Effluent in m3, Rest all figs in kg.
Stage Effluent in m3
Solvent
Residue
Carbon Hyflow Spent
Solvent
Gas
Generated
Inorganic
Salt
Organic
Residue LCOD HCOD Name Qty
I ------ ------ ------ 10 4 120 ---- --- ------- -------
M ------- ----- ------- 400 160 4828 ------ ---- -------
D -------- ----- ------ 16 6.40 193.12 ------ --- ----- -----
M- Pollution load per month, D- Pollution load per day.
H2/N2 gas is not generated but used as reactant and blanketing, excess gas is released
through water.
Carbon is an catalyst and hence not included as HW, It is send to processing and recycled.
Table No. 3:- Solvent Balance of Salbutamol Sulphate
Sr.No/
Stage
Qty in Kg/Day
Name of
the
solvent
Qty
Used
Recovered
[Distilled]
Fugitive
loss
Distillation
Process
loss
To
waste
Water
Distillation
Residue
Product
drying
loss
Spent
Solvent
Fresh
Make
Up
I Methanol 665. 472.50 Nil 11.76 ----- --- 20 Nil 192.50
Table No. 4:- Matrix showing Molecular weight, Moles, molar ratio and consumption
The below figures of the respective raw material are representative of a batch. Name of
Key RM
Details Mol.Wt Qty
kg
Moles Molar
Ratio
Existing
Consumption
Proposed
Consumption
Net
Consumption
Benzyl
Salbutamol
Reactant
329
66.70 0.202 1 ---- ---- ----
Methanol Solvent ----- 416 ----- ---- ---- 116 116
Raney Ni Catalyst ---- 10 --- --- ---- ---- ---
Sulphuric
acid
Reagent 98 10 0.10 0.50 ---------- 10 10
Note: - Solvents is in terms of volume and not based on mole ratio.
Key Raw materials are considered as they are involved to build the desired molecule.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 121
18. Product Name- Pantoprazole Sodium
Qty/Month 450.00kg.
Batch Output 150 kg
No of Batches/ Month 3
No of working days 25
Brief Process Description-
2 Chloromethyl -3, 4-dimethoxy pyridine hydrochloride is condensed in toluene and NaOH as
reagent for neutralizing hydrochloric acid formed.
After the reaction is over, water is added and reaction mass is stirred and cooled. The reaction mass
is centrifuged, washed with water and spin dried, unloaded and used for next stage.
Stage I is charged in solution sodium hypochlorite, sodium hydroxide and toluene as solvent. The
reaction mass is heated to reflux temperature and maintained for 3-5 hrs. After the reaction is
complete, the reaction mass is cooled and settled. Toluene is separated and subjected for
distillation to recovered Toluene and recycled. The solvent residue is send to CHWTSDF for
disposal. Water is added to the reaction mass and centrifuged, washed with water, spin dried and
unloaded. The wet product is charged in acetone and heated to get a clear solution. Carbon is added
and filtered through SPF [Sparkler pressure filter]. The filtrate is transferred to a clean Reactor and
cooled to ambient and then chilled to 0-5 °C, maintained for 2 hrs and centrifuged. The wet product
is unloaded and dried in tray dryer to get dry Pantoprazole sodium as final product
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 122
Route of Synthesis of Pantoprazole Sodium Stage I
N
OCH3
OCH3
CH2Cl
2-(chloromethyl)-3,4-dimethoxypyridine
Mol.Wt 224
. HCl .+
N
NH
HS
OCHF2
5-(difluoromethoxy)-1H-benzo[d]imidazole-2-thiol
Mol.Wt 216
5-(difluoromethoxy)-1H-benzo[d]imidazole-2-thiol
1. Tolueen , NaOH
2. water
N
OCH3
OCH3
.
S
HN
N
OCHF2
+2NaCl +2H2O
2-((3,4-dimethoxypyridin-2-yl)methylthio)-5-(difluoromethoxy)-1H-benzo[d]imidazole
Mol.Wt 367
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 123
Route of Synthesis of Pantoprazole Sodium Stage II
N
OCH3
OCH3
.
S
HN
N
OCHF2
2-((3,4-dimethoxypyridin-2-yl)methylthio)-5-(difluoromethoxy)-1H-benzo[d]imidazole
Mol.Wt 367
N
OCH3
OCH3
.
S
HN
N
OCHF2
1. Sodium Hypochlorite2. Toluene3.Water O
2-((3,4-dimethoxypyridin-2-yl)methylsulfinyl)-5-(difluoromethoxy)-1H-benzo[d]imidazole
Mol.Wt 383
1.Acetone
2.NaOH
N
OCH3
OCH3
.
S
N
N
OCHF2
O
Na
PENTAPRAZOLE SODIUM
MOL.WT 406
Table No.1:- Batch Input and output and mass Balance of Pantoprazole Sodium Stage I
Input UOM Qty Output Qty Remark
2- Chloromethyl-3-4-dimethoxy pyridine hydrochloride
kg 94 Stage I 151 Used for Stage II
5-Difluoro methoxy-2-mercapto benzimidazole
kg 91 Sodium Chloride 48.80 To Waste Water
Sodium Hydroxide kg 34 Aq. Effluent 4890 To ETP for treatment
Water kg 4875 Toluene 346 Rec and used
Toluene kg 360 Toluene 0.9 Recovery loss
HCl kg 0.7 Toluene 3.6 To waste Water
Toluene 14.40 Solvent distillation residue contains unreacted stage I/II
Total kg 5454.70 Total 5454.70 -------
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 124
Table No. 2:-Pollution load of Pantoprazole Sodium Stage I.
Effluent in m3, Rest all figs in kg.
Stage Effluent in m3
Solvent
Residue
Carbon Hyflow Spent
Solvent
Gas
Generated
Inorganic
Salt
Organic
Residue LCOD HCOD Name Qty
I ------ 4.942.0 14.40 ---- ----- ---- ---- --- ------- -------
M ------- 14.8272 43.20 ----- ----- ----- ------ ---- -------
D -------- 0.593 1.728 ----- ------ ----- ------ --- ----- -----
M- Pollution load per month, D- Pollution load per day.
Table No. 3:- Solvent Balance of Pantoprazole Sodium Stage I
Sr.No/
Stage
Qty in Kg/Day
Name
of the
solvent
Qty
Used
Recovered
or
Distilled
Fugitive
loss
Distillation
Process
loss
To
waste
Water
Distillation
Residue
Product
drying
loss
Spent
Solvent
Fresh
Make
Up
I Toluene 43.20 41.52 Nil 0.108 0.432 1.728 --- Nil 1.68
I Water 586.80 --------- ------ ------ 586 -- --- ---- 586
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 125
Table No. 4:- Batch Input and Output and Mass Balance of
Pantoprazole Sodium Stage II
Input UOM Qty Output Qty Remark
Stage I kg 151 Stage II 150 Final Product
Sodium Hypochlorite 4% kg 766 Sodium Chloride 24 To waste water
Sodium Hydroxide kg 16 Effluent aq. 1193 To ETP for treatment
Toluene kg 600 Toluene 576 Recovery and use
Acetone kg 750 Toluene 1.2 Distillation loss
Carbon kg 15 Toluene 9 To waste water
Water kg 450 Solvent Residue 28.90
---------------------- Kg ------ Carbon 15 TO CHWTSDF
---------------------- Kg ------ Acetone 684 Rec and used
---------------------- Kg ------ Acetone 12 Distillation loss
---------------------- Kg ------ Acetone sol. Residue 14.10 Acetone distillation Residue
---------------------- kg ------ Acetone 15 Product drying loss
--------------------- kg ---- Carbon 15 TO CHWTSDF as HW
Total kg 2748 Total 2748
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 126
Table No. 5:-Pollution load Pantoprazole Sodium Stage II.
Effluent in m3, Rest all figs in kg. Stage II
Stag
e
Effluent in
m3
Solvent
Residu
e
Carbo
n
Hyflo
w
Spent
Solven
t
Gas
Generated
Inorgani
c
Salt
Organi
c
Residu
e LCO
D
HCO
D
Nam
e
Qt
y
I ------ 1.214 43 15 ----- ---- ---- --- ------- -------
M ----- 3.642 129 45 ----- ----- ----- ---- --- ----
D ---- 0.145 5.16 1.80 ------ ------ ----- ---- ---- ----
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 127
Table No.6 :- Solvent Balance of Pantoprazole Sodium Stage II
Sr.No/
Stage
Qty in Kg/Day
Name
of the
solvent
Qty
Used
Recovered
or
Distilled
Fugitive
loss
Distillation
Process
loss
To
waste
Water
Distillation
Residue
Product
drying
loss
Spent
Solvent
Fresh
Make
Up
II Toluene 72 69.12 ----- 1.44 1.08 3.468 ---- --- 2.88
II Acetone 90 82.08 ---- 1.44 ---- 1.692 1.80 --- 8.0
II Water 54 ------ ------ ---- 54 ---- --- ---- 54
Table No.7 :- Cumulative Pollution load of Pantoprazole Stage I/II
Stag
e
Effluent in
m3
Solvent
Residu
e
Carbo
n
Hyflo
w
Spent
Solven
t
Gas
Generated
Inorgani
c
Salt
Organi
c
Residu
e LCO
D
HCO
D
Nam
e
Qt
y
I/II ------ 0.738 6.888 1.80 ----- ---- ---- --- ------- -------
Table No 8:- Matrix showing Molecular weight, Moles, molar ratio and consumption
The below figures of the respective raw material are representative of a batch.
Name of Key RM
Details Mol.Wt
Qty kg
Moles
Molar
Ratio
Existing Consumptio
n
Proposed Consumptio
n
Net Consumptio
n
RM I Reactant 224 94 0.419 1.0 ---------- 94 94
RMII Reactant 216 91 0.421 1.005 ------------ 91 91
Sodium
Hydroxid
e
Reagent 40 34 0.85 2.0 ----------- 40 40
Toluene Solvent ----- 360 ---- --- ------ 14 14
Water Solvent ----- 487
5
---- --- ------ 4875 4875
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 128
Stage II Reactan
t
------ 151 ------ ----- -------- 151 151
NaOCL Reactan
t
------- 766 ------ ----- -------- 766 766
Toluene Solvent ------- 600 ------ ----- ------ 24 24
Acetone Solvent ----- 750 ---- ---- ------ 76 76
Note: - Solvents is in terms of volume and not based on mole ratio.
Key Raw materials are considered as they are involved to build the desired molecule
19. Product Name- Fenofibrate Qty/Month 500.00kg.
Batch Output 50 kg
No of Batches/ Month 10
No of working days 25
Brief Manufacturing Process-
STAGE 1:
Starting materials 4-chloro-4-hydroxy benzophenone,Isopropyl alcohol and Potassium
Carbonate are added into the reaction vessel and agitated until reaction is completed.
Isopropyl alcohol was added and reaction mass is filtered. The Potassium Bicarbonate and
Potassium bromide is recovered as distillation residue.
The recovered Isopropyl alcohol is used for further use after centrifuge.
STAGE 2:
Starting materials stage 1 product; Isopropyl alcohol and carbon are added into the reaction
vessel and stirred until reaction is completed.
The recovered Isopropyl alcohol is used for further use after centrifuge.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 129
Table No. 1:- Input and output and mass Balance
Input UOM Qty Output Qty Remark
Isopropyl –alpha bromoisobutyrate
Kg 41.0 Crude Fenofibrate 54.0 Final Product
4-Chloro 4- hydroxy benzophenone
Kg 73.5 Isopropyl alcohol 131 Recovered and recycled
Isopropyl alcohol Kg 162.5 Isopropyl alcohol 3.30 Evaporation Loss
Potassium Carbonate kg 27.0 Solvent distillation Residue
69.00 Unreacted RMI and II and solvent IPA as residual part.
-------------- --- ---- Potassium bi carbonate 19.50 For resale to authorized Recycler
-------------------- ----- ---- Potassium bromide 23.20 For resale to Recycler
-------------- ----- IPA in crude FENOFIBRATE
04.00 Used as such for purification
Total 304.0 304.0
Route of Synthesis-
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 130
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 131
Table No. 2:-Pollution load. Effluent in m3, Rest all figs are in kg
Stage Effluent in M3
Solvent Residue
Carbon Hyflow
Spent Solven
t
Gas Generated
Inorganic Salt
Organic Residue LCOD HCOD Name Qty
I -- -- 4.0 -- -- -- SO2 HCl HBr
90.45 120.75 165.90
42.70 --
II -- -- 69 2.5 0.350 -- CO2 193.05 ----- -- M -- -- 730 25.0 3.50 -- SO2
HCl HBr CO2
904.5 1207.5 1659.0 1930.5
427 --
D -- -- 29.20 1.0 0.140 -- SO2 HCl HBr CO2
36.18 48.3
66.36 77.22
17.08 --
M- Pollution load per month- Pollution load per day.
The reaction is not exothermic or run away or pressure.
Table No 3: - Solvent Balance of Fenofibrate. Stage I/II
Sr.No
/
Stage
Qty in Kg/Day
Name of
the
solvent
Qty
Used
Recovered
[Distilled]
Fugitiv
e loss
Distillatio
n
Process
loss
To
wast
e
Wate
r
Dist
illat
ion
Resi
due
Produ
ct
dryin
g loss
Spen
t
Solve
nt
Fresh
Make Up
I Isopropy
l alcohol
65 52.40 ---- 1.32 -- 27.6
0
-- -- 12.60
II Isopropy
l alcohol
46.60 36.80 --- 2 -- 1.60 7.80 -- 9.80
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 132
Table No 4: - Matrix showing Molecular weight, Moles, molar ratio and consumption
Name of
Key RM
Details Mol.
Wt
Qty
kg
Moles Molar
Ratio
Existing
Consumption
Proposed
Consumptio
n
Net
Consumpt
ion
Isopropyl –alpha
bromoisobutyrate
Reactant 209.0
8
41.0 0.19 1.27 --- 410 410
4-Chloro 4-
hydroxy
benzophenone
Reactant 235.5 73.5 0.312 2.09 --- 735 735
Isopropyl alcohol Solvent 60.1 162.5 --- --- --- 310 310
Potassium
Carbonate
Reagent 139.0 27.0 0.194 1.30 --- 270 270
Crude
Fenofibrate
Reactant 360.8 54.0 0.149 1.00 --- 540 540
Isopropyl alcohol Solvent 60.1 116.5 --- -- --- 240- 240
Activated Carbon Catalyst 12.01 2.5 --- --- --- 25 25
Hyflo Filtration
Media
NA 0.35 --- --- --- 3.5 3.5
Note: - Solvents is in terms of volume and not based on mole ratio. Key Raw materials are
considered as they are involved to build the desired molecule. The above figures of the
respective raw material are representative of a batch.
20. Product Name- Clopidogrel Hydrogen Sulphate Qty/Month 175.00kg.
Batch Output 87.50 kg
No of Batches/ Month 2
No of working days 25
Brief Process Description- In clean Reactor Acetone is charged at ambient. Clopidogrel base is charged at ambient under
stirring. The reaction mass stirred and ensured a clear solution, if not add additional Acetone to
have clear solution. The reaction mass is cooled below 10 °C and slow sulphuric acid is added. After
complete addition, the reaction mass temperature is maintained below 20 0c and then centrifuged.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 133
The wet cake is washed with chilled Acetone and unloaded. The wet product as Clopidogrel
Hydrogen Sulphate is dried to get dry Clopidogrel Hydrogen Sulphate.
Route of Synthesis-
N
Cl
+
S
O OCH3
methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate
Mol.Wt 321.82
1.Acetone
2.H2SO4
N
ClS
O OCH3
. HSO4
CLOPIDOGREL HYDROGEN SUPLphate MOL.WT 419
Table No 1:- Batch Input and output and mass Balance Clopidogrel Hydrogen Sulphate
Input UOM Qty Output Qty Remark
Clopidogrel Base kg 68.50 Clopidogrel Sulphate 87.50 Final Product Acetone kg 350 Acetone 330 Rec and Recycled
Sulphuric acid Kg 20.50 Acetone 2.5 Process Loss -------------------- kg ---- Solvent Residue 9.0 Recycled
------------------------- kg ---- Drying Loss 10 Drying Operation
Total kg 439 Total 439
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 134
Table No.2 :--Pollution load of Clopidogrel Hydrogen Sulphate.
Effluent in m3, Rest all figs in kg.
Stage Effluent in m3
Solvent
Residue
Carbon Hyflow Spent
Solvent
Gas
Generated
Inorganic
Salt
Organic
Residue
LCOD HCOD Name Qty
I ------ ------ ------ ---- ----- ---- ---- --- ------- -------
M ---- ----- ------ ----- ----- ----- ------ ----- ---- ------
D ------ ------- ------- ----- ---- ----- ----- ---- ---- ------
M- Pollution load per month, D- Pollution load per day.
All operations are in solvent. The solvent residue is recycled and hence no pollution of any kind
as mentioned different heads.
Table No. 3:- Solvent Balance of Clopidogrel Hydrogen Sulphate
Sr.No/ Stage
Qty in Kg/Day Name of the
solvent
Qty Used
Recovered or
Distilled
Fugitive loss
Distillation Process
loss
To waste Water
Distillation Residue
Product drying
loss
Spent Solvent
Fresh Make
Up
I Acetone 56 26.40 ----- 0.20 ---- 9 0.80 --- 29.60
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 135
Table No.4 :- Matrix showing Molecular weight, Moles, molar ratio and consumption
The below figures of the respective raw material are representative of a batch.
Note: - Solvents is in terms of volume and not based on mole ratio.
Key Raw materials are considered as they are involved to build the desired molecule.
21. Product Name- Rosuvastatin Calcium
Qty/Month 500.00kg.
Batch Output 100 kg
No of Batches/ Month 5
No of working days 25
Brief Process Description-
Rosuvastatin intermediate as acid is charged in methanol at ambient under stirring in clean
Reactor. Sodium Hydroxide flakes are added to the reaction mass and heated to reflux .Reflux is
maintained for 2-4 hrs till complete conversion to sodium salt is over. The reaction mass is cooled
to ambient and calcium acetate is added, the reaction mass is stirred for 10-15 minutes and heated
to 50-55 °C and maintained for 1 hr. The reaction mass is cooled to ambient and filtered .The solid
salt of sodium acetate is separated and sold to recycler. The clear filtrate is transferred to another
reactor and distilled of completely, the reaction mass is cooled water is added followed by MTBE.
The reaction mixture is stirred and settled. The aq layer is send to ETP and MTBE organic layer
having product is transferred to another Reactor and, Carbon is added and heated to 55-60 °C. The
hot filtrate is filtered and the clear filtrate is transferred to another clean Reactor and chilled to 0-5
°C and maintained for 2 hrs at 0-5 °C. The product is centrifuged and spin dried. The mother liquor
is distilled to get rec. MTBE for recycling. The solvent residue left behind is unloaded and send to
CHWTSDF for disposal.
Name of Key RM
Details Mol.Wt Qty kg
Moles Molar Ratio
Existing Consumption
Proposed Consumption
Net Consumption
Clop Base
Reactant 321 68.50 0.21 - ------ 58.50 68.50
Acetone Solvent ------ 350 ---- --- --------------- 20 20 Sulphuric
Acid Reagent 98 20 0.20 0.97 ----- 20 20
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 136
Route of Synthesis of Rosuvastatin Calcium
F
N
NN
S
OO
OH
O
1(3R,6S,6E)-3,5-DIHydroxy-7-[4-(4-Fluorophenyl)-6-(1-methyl ethyl)-2[methyl, methyl sulphonyl) amino]-5- pyrimidyl]-6-methylhepteneoate
Mol.wt 481
OH OH
1. NaOH , CALCIUM ACETATE, METHANOL , MTBE
CARBON, HYFLOW, WATERF
N
NN
S
OO
OCa
O
Mol.wt 522
OH OH
ROSUVASTATIN CALCIUM
Table No. 1:- Batch Input and output and mass Balance of Rosuvastatin Calcium
Input UOM Qty Output Qty Remark
Rosuvastatin Intermediate I
kg 116.70 Rosuvastatin Calcium 100 Final Product
Sodium Hydroxide kg 9.40 Sodium Acetate 18.50 Sale to Recycler
Calcium acetate kg 18.60 Methanol 550 Rec and recycled
Methanol kg 600 Methanol 10 Distillation loss
MTBE kg 500 Methanol 40 To waste water
Activated Carbon kg 5 MTBE 440 Recovered and used
Hflow kg 2.50 MTBE 05 Distillation loss
Water kg 500 MTBE 20 Product drying loss
-------------------- kg ------ MTBE 05 To Waste Water
-------------------------- kg ----- Aq. Effluent 500 To ETP for treatment
--------------------------- kg ------ MTBE solvent Residue 56.20 Distillation Residue
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 137
----------------------- kg ----- Carbon 5 To CHWRSDF
---------------------- kg ----- Hyflow 2.50 TO CHWTSDF
Total kg 1752.20 Total 1752.20 --------
MTBE- Methyl tertiary butyl ether.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 138
Table No.2 :-Pollution load of Rosuvastatin Calcium
Effluent in m3, Rest all figs in kg.
Stage Effluent in
m3
Solvent
Residue
Carbon Hyflow Spent
Solvent
Gas
Generated
Inorganic
Salt
Organic
Residue LCOD HCOD Name Qty
I ------ 0.545 56.20 5 2.5 ---- ------ ----- 18.50 -------
M ---- 2.725 281 25 12.50 ----- ----- ----- 92.50 ------
D ------ 0.109 11.24 1 0.50 ----- ------ ------ 3.70 ------
M- Pollution load per month, D- Pollution load per day.
Table No 3:- Solvent Balance of Rosuvastatin Calcium
Sr.No/ Stage
Qty in Kg/Day Name of
the solvent
Qty Used
Recovered or
Distilled
Fugitive loss
Distillation Process
loss
To waste Water
Distillation Residue
Product drying
loss
Spent Solvent
Fresh Make
Up
I Methanol 120 110 ------ 2 8 --- --- --- 10
I MTBE 100 88 ------- 1 1 11.24 4 ---- 12
Table No.4 :- Matrix showing Molecular weight, Moles, molar ratio and consumption
The below figures of the respective raw material are representative of a batch.
Name of Key RM
Details Mol.Wt Qty kg Moles Molar Ratio
Existing Consumption
Proposed Consumption
Net Consumption
Rosuvastatin
RM1
Reactant 481 116.70 0.242 1 ---------- 116.70 116.70
Cal Acetate Reactant 99 18.60 0.18 0.71 ----------- 18.60 18.60
NaOH Reagent 40 9.40 0.235 0.896 ------- 9.40 9.40
Methanol Solvent ---- 600 --- --- ------ 50 50
MTBE Solvent ---- 500 --- --- --- 60 60
Note: - Solvents is in terms of volume and not based on mole ratio.
Key Raw materials are considered as they are involved to build the desired molecule
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 139
22. Product Name- Domperidone Qty/Month 100.00kg.
Batch Output 50 kg
No of Batches/ Month 2
No of working days 25
Brief Process Description for – Domperidone
3-Chloro Phenyl Bnezimidazole is condensed with Chloro phenyl benzo imidazole one in presence
of sodium carbonate and methyl isobutyl ketone at reflux temperature. The reflux is maintained for
5-8 hrs, till completion of the reaction. The reaction completion is ensured on TLC. If the reaction is
complete, the reaction mass is cooled to ambient and water is added, stirred and settled. Aq.Layer is
separated and sends to ETP for treatment. The organic layer containing product Domeperidone is
cooled to ambient and then to 0-5 °c, stirred for 2 hrs and centrifuged. The wet product is dried in
tray dryer to get dry Domeperidone.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 140
Route of Synthesis of Domperidone
N
HN
O
NH
Cl
5-chloro-1-(piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one
Ml.Wt 251.70
+
N
HN
O
Cl
1-(3-chloropropyl)-1H-benzo[d]imidazol-2(3H)-one
Mol.Wt 210.06
1. MIBK , SODIUM CARBONATE, WATER
N
HN
O
N
Cl
N NH
O
1-(3-(4-(6-chloro-1,2-dihydro-2-oxobenzo[d]imidazol-3-yl)piperidin-1-yl)propyl)-1H-benzo[d]imidazol-2(3H)-one
DOMEPERIDOBE MOL.WT 425.91.
Table No. 1:- Batch Input and output and mass Balance of Domperidone
Input UOM Qty Output Qty Remark
Chloro Phenyl Benzimidazole RMI
kg 51 Product Domperidone 50 Final Product
3-Chloro Phenyl benzo imidazole one RMII
kg 31.1 0 Carbon di oxide 2.60 Let to Atmosphere
Methyl Isobutyl Ketone kg 250 Aq.Effluent HCOD 246..75 To ETP for treatment
Sodium Carbonate kg 6 Sodium Chloride formed 6.85 To waste water
Water kg 220 MIBK 230 Rec and recycled
--------------------------- kg ----- MIBK 1.9 Distillation loss
------------------ kg ----- MIBK 10 Solvent dis.Residue
-------------------------- kg ----- MIBK 10. Product drying loss
Total kg 558.10 Total 558.1 -----------
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 141
Table No.2 :-Pollution load of Domperidone
Effluent in m3, Rest all figs in kg
Stage Effluent in m3
Solvent
Residue
Carbon Hyflow Spent
Solvent
Gas
Generated
Inorganic
Salt
Organic
Residue LCOD HCOD Name Qty
I ------ 0.2536 10 ------ ----- ---- CO2 2.60 ------- -------
M ---- 0.50720 -20 ----- ----- ----- CO2 5.20 ---- ------
D ------ 0.020 0.80 ----- ---- ----- CO2 0.208 ---- ------
M- Pollution load per month, D- Pollution load per day.
Table No.3 :- Solvent Balance of Domperidone
Sr.No/ Stage
Qty in Kg/Day Name of the
solvent
Qty Used
Recovered or
Distilled
Fugitive loss
Distillation Process
loss
To waste Water
Distillation Residue
Product drying
loss
Spent Solvent
Fresh Make
Up
I MIBK 20 18.40 ----- 0.152 ----- 0.80 0.80 --- 1.6
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 142
Table No. 4:- Matrix showing Molecular weight, Moles, molar ratio and consumption
The below figures of the respective raw material are representative of a batch.
Name of
Key RM
Details Mol.Wt Qty
kg
Moles Molar
Ratio
Existing
Consumption
Proposed
Consumption
Net
Consumption
RMI Reactant 251.70 51 0.202 1 ------- 51 51
RMII Reactant 210.06 31.1 0.148 0.732 ---------- 31.1 31.1
Sodium
Carbonate
Reagent 106 6 0.05 0.280 ---------- 06 06
MIBK Solvent ----- 250 ----- ---- ----------- 30 30
Water Solvent ---- 220 --- ---- -------- 220 220
Note: - Solvents is in terms of volume and not based on mole ratio.
Key Raw materials are considered as they are involved to build the desired molecule.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 143
23. Product Name- Nebivolol Intermediate Qty/Month 350.00kg.
Batch Output 125 kg
No of Batches/ Month 2.8
No of working days 25
Brief Process Description for – Nebivolol Intermediate Stage I
[6-Fluoro 3, 4 Dihydro Piperdine Methanone is treated with vitride 4 % solution in toluene at
reflux temperature. The resultant reaction mass is quenched in HCl / Water mixture. The reaction
mass after quenching is stirred and settled. The toluene layer is washed with water and then
distilled to get a residual mass, which is cooled and unloaded; this residual mass is used for next
stage.
Stage II
The residual mass as stage I is charged in DMSO. Trimethy sulfonium iodide is charged and the
reaction mass is heated to 50-60 °C and maintained for 4 hrs. Reacting completion is ensured on
TLC. If the reaction is complete, the reaction mass is cooled to ambient and quenched in water. The
product of stage II is extracted in n-hexane. The aq layer is let to ETP and hexane layer containing
product is distilled to 80 % and then cooled to ambient and chilled further to 0-5°C and centrifuged
under nitrogen blanket to get stage II- Nebivolol intermediate. The wet product is dried in tray
dryer to dry product.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 144
Route of Synthesis of Nebivolol Intermediate Stage I
O
F
N
O
(6-fluoro-3,4-dihydro-2H-chromen-2-yl)(piperidin-1-yl)methanone
Mol. Wt-263.31
+
Vitride
Mol.Wt 202
[ Sodium -Bis [ 2-methoxyethoxy] Aluminium hydride
HCl / Water
O
F
O
6-fluoro-3,4-dihydro-2H-chromene-2-carbaldehyde
Mol/. wt 180
Route of Synthesis of Nebivolol Intermediate Stage II
O
F
O
6-fluoro-3,4-dihydro-2H-chromene-2-carbaldehyde
Mol/. wt 180
+TRIMETHYL SULPHONIUM HYDRIDE
Mol. Wt 220
1. KOH
2.DMSO
3. HEXANE
O
F
+
O
6-fluoro-3,4-dihydro-2-(oxiran-2-yl)-2H-chromene
Mol. Wt--154
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 145
Table No.1 :- Batch Input and output and mass Balance Intermediate Stage I of Nebivolol
Input UOM Qty Output Qty Remark
6-Fluoro 3,4-dihydro methanone RMI
kg 250 Liquid reaction mass
170 Used for stage II
Vitride 192 Aq.Layer 722 To ETP for treatment
Toluene kg 300 Toluene 745 Rec and used
Tolueen in Vitride kg 450 Toluene 05 Distillation loss
HCL 30 kg 50 ------------------- ------ --------------
Water kg 400 ------------------ ----- --------------------
Total kg 1642 Total 1642 --------------
Table No. 2:-Pollution load of Nebivolol Intermediate Stage I
Effluent in m3, Rest all figs in kg.
Stage Effluent in m3
Solvent
Residue
Carbon Hyflow Spent
Solvent
Gas
Generated
Inorganic
Salt
Organic
Residue LCOD HCOD Name Qty
I ------ 0.722 ------ ---- ----- ---- ---- --- ------- -------
M ---- 2.021 ------ ----- ----- ----- ------ ----- ---- ------
D ------ 0.080 ------- ----- ---- ----- ----- ---- ---- ------
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 146
Table No. 3:- Batch Input and output and mass Balance of Nebivolol Intermediate Stage II
Input UOM Qty Output Qty Remark
Stage I Residue kg 170 Nabivolo Int I 125 Used for stage II
Trimethyl Sulfonium Iodide kg 183 Aq.Effluent 600 To ETP for Recycling
KOH kg 46 DMSO 200 To waste Water
DMSO kg 200 Hexane 160 Rec and used
Water kg 400 Hexane 10 Distillation loss
Hexane kg 200 Solvent Residue 84 TO CHWTSDF
------------------------- kg ----- Drying Loss 20 Evaporation loss
Total kg 1199 Total 1199 ------------
Table No. 4:-Pollution load of Nebivolol Intermediate Stage II.
Effluent in m3, Rest all figs in kg
Stage Effluent in m3
Solvent Residue
Carbon Hyflow Spent Solvent
Gas Generated
Inorganic Salt
Organic Residue LCOD HCOD Name Qty
II ------ 0.800 84 ---- ----- ---- ---- --- ------- ------- M ------- 2.24 235.20 ----- ----- ----- ------ ---- -------
D -------- 0.0896 9.408 ----- ------ ----- ------ --- ----- -----
M- Pollution load per month, D- Pollution load per day.
Prefeasibility Report: QPPL/2018/01
Quantinental Pharmachem Private Limited (QPPL) P a g e | 147
Table No. :- Solvent Balance of Nebivolol Intermediate Stage II
Sr.No/ Stage
Qty in Kg/Day Name of the
solvent
Qty Used
Recovered or
Distilled
Fugitive loss
Distillation Process
loss
To waste Water
Distillation Residue
Product drying
loss
Spent Solvent
Fresh Make
Up
I Toluene 84 83.44 ----- 2.11 ---- --- --- --- .065
I DMSO 22.40 ------ ------ ------- 22.40 ----- --- --- 200
I/II Water 89.60 ------ ----- ---- 89.60 --- --- --- 89.60
II Hexane 22.40 17.92 ------ 1.12 ----- 9.40 2.24 4.48
Table No. :- Cumulative Pollution Load of Nebivolol Intermediate Stage II
Effluent in M3, Rest all in kgs
Stage Effluent in m3
Solvent
Residue
Carbon Hyflow Spent
Solvent
Gas
Generated
Inorganic
Salt
Organic
Residue LCOD HCOD Name Qty
I/II ------ 0.169 9.408 ---- ----- ---- ---- --- ------- -------
Table No. :- Matrix showing Molecular weight, Moles, molar ratio and consumption
The below figures of the respective raw material are representative of a batch.
Name of
Key RM
Details Mol.Wt Qty
kg
Moles Molar
Ratio
Existing
Consumption
Proposed
Consumption
Net
Consumption
RMI Reactant 263 250 0.95 1 ------ 250 250
Vitride Reactant 202 192 0.95 1 --------------- 192 192
Toluene Solvent ---- 750 ----- ---- ----- 5 5
Stage I Reactant 180 170 0.944 ------ ----------- 170 170
KOH Reagent 56 46 0.82 0.87 ----- 46 46
DMSO Solvent ------ 200 ---- ---- ----- 200 200
Water Solvent ----- 800 ---- --- -------- 800 800
Hexane Solvent ----- 200 --- --- ----- 40 40
Note: - Solvents is in terms of volume and not based on mole ratio.
Key Raw materials are considered as they are involved to build the desired molecule.